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The vaginal microbial community is critical to a woman’s health and the health of 
her family. Bacterial vaginosis (BV) is a polymicrobial syndrome characterized by a shift 
of the vaginal microbiota from a Lactobacillus dominated community to a dense biofilm 
containing a complex mixture of organisms. Although BV is an important risk factor for 
poor reproductive health outcomes, the etiology of BV is poorly understood.   
Gardnerella vaginalis is a hallmark species of BV. Phylogenetic analysis of 
cpn60 universal target sequences from metagenomic studies of the vaginal microbiome 
and from G. vaginalis isolates resolved four subgroups within the species. This 
subdivision, supported by whole genome similarity comparisons, demonstrated that these 
subgroups might represent different species. Among a group of African women, only G. 
vaginalis subgroup B was significantly more abundant in women with BV relative to 
women with Nugent scores not consistent with BV. To characterize the subgroups 
further, several phenotypic and molecular factors of G. vaginalis subgroups were 
assessed. Proteomic profiles of isolates within each subgroup formed unambiguous 
clusters. Sialidase gene sequences were detected in all subgroups, however enzymatic 
activity was detected only in subgroup B. Two isolates of subgroup B isolates (N153 and 
N101) were incapable of growth in 7% CO2. Given the well-known relationship between 
an anaerobic microbiota and BV, anaerobic isolates of G. vaginalis are potentially 
important players in the vaginal microbial community. To determine genome content 
differences that could account for the phenotypic difference, whole genome sequences of 
four G. vaginalis subgroup B isolates representing facultative and anaerobic phenotypes 
were determined. Comparison of genomes led to the identification of genes predicted to 
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encode proteins involved in cell wall biogenesis and protection from oxidative damage 
that might account for the observed phenotypes.   
The cpn60 universal target based methodology that improved resolution of the 
vaginal microbiota including G. vaginalis was applied in a prospective study of the 
vaginal microbiome of women with preterm premature rupture of membranes (PPROM). 
The objectives were to characterize the vaginal microbiota of women following PPROM, 
and to determine if microbiome composition at the time of rupture predicts latency 
duration and perinatal outcomes. Only 13/70 samples collected from 36 women were 
dominated by Lactobacillus spp., the expected profile for healthy women, while 
Megasphaera type 1 and Prevotella spp. were detected in all samples. Microbiome 
profiles at the time of membrane rupture did not cluster by gestational age at PPROM, or 
latency duration. Microbial profiles were unstable over the latency period, with dramatic 
shifts in composition between weekly samples, and an overall decrease in Lactobacillus 
abundance. Mollicutes were detected by PCR in 81% (29/36) of women, and these 
women had significantly lower gestational age at delivery and correspondingly lower 
birth weight infants than Mollicutes negative women.  
Taken together, the results presented in this thesis demonstrate the value of high 
resolution profiling of the vaginal microbiome using cpn60 UT sequences. The resolution 
of subgroups within G. vaginalis has potentially significant implications for women's 
health diagnostics, requiring a shift away from considering G. vaginalis as a single entity. 
The PPROM study provides foundational information that may lead to the identification 
of informative sequence patterns, providing clinicians with better tools for expectant 
management following PPROM. 
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CHAPTER 1 -  Introduction and literature review 
1.1 The vaginal microbiome  
The vaginal microbiome, a complex microbial community residing in the vagina, 
is a dynamic ecosystem susceptible to changes in structure and composition of species 
present. The delicate equilibrium that exists between vaginal epithelial cells and the 
microbial community can be disturbed, resulting in an unbalanced microbial community. 
Such imbalances in the vaginal microbial community can cause conditions such as 
bacterial vaginosis (BV) (Spiegel 1991), yeast infections (Egan and Lipsky 2000)  and 
pelvic inflammatory disease (PID) (Ness et al. 2004). A disturbed microbial community 
also increases susceptibility to sexually transmitted diseases (Myer et al. 2005) such as 
chlamydia (caused by Chlamydia trachomatis), trichomoniasis (caused by Trichomonas 
vaginalis) and acquired immunodeficiency syndrome (AIDS, caused by HIV). Perturbed 
vaginal microbiota is also associated with preterm birth and preterm rupture of 
membranes (Leitich et al. 2003).  
A healthy vaginal ecosystem has been traditionally defined by the dominance of 
certain Lactobacillus species, which suppress the overgrowth of other endogenous 
bacteria by the production of lactic acid, H2O2, and bacteriocins (Dover et al. 2008; 
O'Hanlon et al. 2013; Summers 2010). However, the vaginal microbial community is a 
dynamic system, with different species attaining dominance throughout a woman's 
lifetime under the influence of variety of host factors such as hormonal changes 
(Eschenbach et al. 2000), vaginal epithelial changes (Sjoberg et al. 1988), metabolites 
available (Huggins and Preti 1976), the host’s genetic make up and mechanisms of innate 
immunity (Cole 2006).  
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Glycogen metabolism in the vagina is known to be critical for the maintenance of 
an acidic pH. Cruickshank and Sharman in 1934 recorded for the first time the presence 
of glycogen in the fetal vagina and also in the infants up until the fourth week of life  
(reviewed by Henderson et al. (1969)). The infant vagina at birth has been shown to 
contain residues of transplacental maternal estrogen. Estrogen causes proliferation of the 
glycogen rich intermediate cell layer of the mucosa, which in turn causes the vaginal 
mucosa of infants to be rich in glycogen. Hence, glycogen in the infant vagina can 
support the growth of lactic acid producing microbes such as lactobacilli. Lactobacilli are 
detected in vagina of infants up to 48 hours after birth. Schroder, Hinrichs and Kessler in 
1926 had proposed that vaginal glycogen was metabolized into simpler carbohydrates, 
which were later metabolized by the lactobacilli (reviewed by Wylie and Henderson 
(1969)). 
Maternal estrogen wanes by the fourth post-natal week causing the infant vaginal 
epithelium to thin out, also losing its glycogen content. During early childhood (1-8 
years), the vaginal pH is either neutral or alkaline due to lack of acid producing microbes 
in the vagina, associated with the lack of glycogen. There is hardly any stimulation by 
adrenal or gonadal steroid hormones in the vagina until puberty (Farage and Maibach 
2006; Farage and Maibach 2011). During the childhood years, the vaginal microbial 
community is composed primarily of enteric microbes and also resembles skin 
microbiota with diphtheroids (corynebacteria) and Staphylococcus epidermidis being 
prominent members of the community (Hammerschlag et al. 1978).  
As puberty begins (between 8 and 13 years of age), adrenal and gonadal glands 
mature, the vaginal epithelium thickens and stratifies, and the production of intracellular 
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glycogen in the vagina ensues (Hammerschlag et al. 1978). Cervicovaginal secretions are 
also produced and prevalence of lactic acid producing microbes rises in the vagina 
(Farage and Maibach 2006). 
During the reproductive years, with menarche approaching and the menstrual 
cycle inducing cyclic hormonal changes, estrogen levels rise and vaginal epithelial 
thickness increases (Summers 2010), also leading to parakeratosis (Nauth and Haas 
1985). Glycogen content in the vagina rises, bringing about the dominance of lactic acid 
producing microbes (Eschenbach et al. 2000). Lactic acid, a byproduct produced by 
vaginal microbiota as well as by vaginal mucosal metabolism, establishes the pH of 
vagina to be acidic, as low as 3.5 (Boskey et al. 2001; O'Hanlon et al. 2013), which is 
indicative of a healthy vaginal environment. Over the course of a menstrual cycle, growth 
of Lactobacillus increases with recovery of non-Lactobacillus spp. being higher only 
during menses, according to the results of culture based studies (Bartlett et al. 1977; 
Eschenbach et al. 2000; Onderdonk et al. 1986). However, results of a more recent 
culture independent study by Chaban et al.,(2014) contradicts this observation of reduced 
Lactobacillus during menses. Another culture independent longitudinal study of two 
consecutive menstrual cycles report reduction in L. crispatus during menses and no 
change in any other Lactobacillus species (Santiago et al. 2011a). 
The most commonly detected species of vaginal Lactobacillus are L. iners, L. 
crispatus, L. gasseri, and L. jensenii (Ravel et al. 2011). During the reproductive years, 
colonization by ‘undesirable’ organisms also occurs and these non-Lactobacillus spp. are 
often associated with unhealthy states such as BV, yeast infection, sexually transmitted 
diseases and urinary tract infections. These ‘undesirable’ taxa that are often isolated from 
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women with abnormal vaginal microbiota include Gardnerella, Staphylococcus, 
Ureaplasma, Corynebacterium, Streptococcus, Peptostreptococcus, Mycoplasma, 
Enterococcus, Escherichia, Veillonella, Bifidobacterium and Candida (Chaban et al. 
2014; Eschenbach et al. 2000; Ravel et al. 2011; Zhou et al. 2004). 
Pregnancy brings about a temporary disruption in the physiology during the 
reproductive years that causes many changes including an increase in blood volume, 
specifically to the vulvar region and relaxation of the connective tissue in the body. The 
menstrual cycle ceases and progesterone and estrogen levels are elevated during gestation 
(Magness 1998). The risk of Candida infection is documented to increase during 
pregnancy (Soong and Einarson 2009; Wallenburg and Wladimiroff 1976). Lactobacillus 
spp. are described to be the predominant members of the microbial community in normal 
pregnancy, with ‘normal’ being defined by the Romero et al. as one without obstetrical, 
medical or surgical complications, and delivery occurring at term (38 to 42 weeks) 
(Romero et al. 2014a). The stability of the vaginal microbial community has been 
reported to be higher in pregnant women than in non-pregnant women and the relative 
abundance of taxa associated with BV such as Atopobium, Prevotella, Sneathia, 
Gardnerella, Ruminococcaceae, Parvimonas, Mobiluncus was found to be lower in 
pregnant women in comparison to non-pregnant women (Romero et al. 2014b). 
During menopause, the follicular function as well as the menstrual cycle ceases 
(Farage and Maibach 2006). The vaginal epithelium atrophies and becomes dry, with a 
distinct reduction in estrogen production in the vagina (Pandit and Ouslander 1997). 
Glycogen content in the vagina decreases, becoming insufficient to support the growth of 
Lactobacillus and other lactic acid producing microbes, which leads to a corresponding 
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rise in vaginal pH. Cervicovaginal secretions become sparse, causing a decline in 
protective mucosal secretions, increasing the likelihood of urinary tract infections and 
vaginal yeast infections (Farage and Maibach 2006; Summers 2010). Atrophic vaginitis is 
also common in postmenopausal women (with low relative abundance of Lactobacillus) 
(Brotman et al. 2014; Pandit and Ouslander 1997). Lactobacilli isolated from 
postmenopausal women such as L. casei are more of gut origin than species associated 
with the vagina of reproductive aged women (Petricevic et al. 2013). Colonization by 
enteric organisms increases and microbes detected in reproductive years such as G. 
vaginalis, Ureaplasma urealyticum, Candida albicans are less frequently isolated from 
postmenopausal women (Hillier and Lau 1997).  
 
1.2 Methodology for studying vaginal microbiota 
Until a decade ago, methods of studying the vaginal microbial community were 
mainly culture based. Culture-based methods have been used for decades for describing 
microbes inhabiting various sites of the human body, including the genital tract of 
women. Culture-based methods have contributed significantly to our current 
understanding of the vaginal microbial community, describing the microbes associated 
with health and disease, and also the physiological and metabolic potential of these 
microbes to a great extent. The concept of a lactobacilli dominated microbiota being 
associated with a healthy genital tract in women is one of the earliest observations based 
on this approach. Understanding of the ability of Lactobacillus to produce lactic acid, 
hydrogen peroxide and bacteriocins suppressing the growth of undesirable microbes in 
vagina was established early on using culture based studies. Similarly, culture-based 
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studies led to the identification of G. vaginalis, Mycoplasma hominis, Bacteriodes, 
Prevotella and Mobiluncus as taxa associated with the most common vaginal disorder, 
BV (Spiegel 1991).  
However, culture based methods do have their disadvantages such as being 
laborious and time consuming. Culture based methods also lead to the isolation of only 
plate-growth-adapted organisms. Many organisms are never isolated due to their special 
nutrient requirements. This in turn leads to a significant underestimation of the diversity 
and richness of the vaginal microbial community of even healthy women. In the face of 
these limitations, culture independent methods provide a more unbiased and complete 
assessment of the vaginal microbial community in healthy and unhealthy states. 
With the introduction of culture independent methods based on DNA 
fingerprinting such as Denaturing Gradient Gel Electrophoresis (DGGE) and Terminal 
Restriction Fragment Length Polymorphism (TRFLP), many bacterial species were 
described as members of the vaginal microbiota and new taxa were associated with health 
and disease (Thies et al. 2007). DGGE based studies resulted in the discovery of 
Lactobacillus iners as an important member of vaginal microbial community (Martin et 
al. 2012). L. iners only grows on blood agar and hence was not considered as important 
as other vaginal lactobacilli, which unlike L. iners grow well on de Man, Rogosa, and 
Sharpe (MRS) agar (Vasquez et al. 2002). With research efforts being steered in the 
direction of sequencing based methods, cloning and single gene based sequencing started 
providing a more complicated picture of vaginal microbiota. cpn60 and 16S rRNA 
became the two most popular gene targets for metagenomic studies. Using these methods, 
significant microbial diversity was reported even within a healthy vaginal microbiota. 
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One of the earlier studies based on cloning and sequencing of 16S rRNA libraries 
described many species for the first time as being part of the vaginal microbial 
community such as Megasphaera and Leptotrichia (Zhou et al. 2004). Similarly the 
earliest study of cpn60 universal target (UT) based sequencing by Hill et al. (2005a) led 
to a high resolution picture of the vaginal microbiota of healthy non-pregnant Canadian 
women. Hill et al. reported for the first time C. psittaci and two other species of the 
family Chlamydiaceae as part of human vaginal microbiota (Hill et al. 2005a). The 
advantage of the cpn60 based method over the 16S rRNA based sequencing has been its 
ability to resolve sequences into phylogenetic groups as shown in case of the sequences 
from the family Chlamydiaceae (Hill et al. 2005a).  
 
1.3 Bacterial vaginosis 
Bacterial vaginosis, historically known as ‘nonspecific vaginitis’, has undergone 
several name changes since mid-1950s. In 1955, when Gardner and Dukes proposed 
Gardnerella vaginalis (then known as Haemophilis vaginalis) as the etiologic agent of 
nonspecific vaginitis, the name for non-specific vaginitis was changed to ‘Haemophilis 
vaginalis vaginitis’ (Gardner and Dukes 1955). With the recognition that there is no 
inflammation present in the vagina with the abnormal discharge during the condition, 
‘vaginosis’ was proposed to be the new name for the syndrome (Holmes et al. 1981). 
However, with increasing knowledge of many different bacterial species being associated 
with the syndrome, term ‘bacterial vaginosis’ was adopted and has been used since then. 
BV is the most common infection for which women seek medical attention and an 
estimated 300 million women worldwide are thought to experience BV each year (Powell 
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2013). Generally, BV is characterized by a shift in the normal microbiome of the vagina 
from the predominant Lactobacillus species to an overgrowth of a mixed community 
dominated by G. vaginalis and anaerobic bacterial species. BV is diagnosed using mainly 
two methods: a microbiologic criterion using the Nugent score, and by specific clinical 
criteria described as Amsel’s criteria. The Nugent score is calculated by observing a 
Gram stain of a vaginal smear. The Nugent score is based on the number of large Gram-
positive rods (Lactobacillus morphotypes), and small Gram-variable rods (G. vaginalis 
morphotypes and Mobiluncus morphotypes).  The score given for the Gram stain of the 
smear ranges from 0 to 10 (Nugent et al. 1991) with 0 - 3 being not consistent with BV 
(normal), 4 - 6 being intermediate and 7 - 10 being consistent with BV. Gram stain 
Nugent scoring is the current gold standard method for diagnosing BV due to its 
reproducibility in the hands of an expert technical staff scoring the Gram stain slide and 
also due to its sensitivity. However, its disadvantages include the requirement of a 
technical staff with years of experience and also requirements of laboratory facilities. 
Other major limitations of Nugent score are that it is quite low resolution and is only 
semi-quantitative. The Nugent score, being based on Gram staining, does not give 
specific information about what bacterial species are present. 
Using Amsel’s criteria (Amsel et al. 1983), a positive clinical diagnosis of BV is 
made when at least three of the four following criteria are present: thin homogeneous 
vaginal discharge, vaginal pH of  ≥ 4.5, positive whiff test (fishy odor on addition of 10% 
KOH to the discharge), or presence of clue cells in a wet mount preparation. When 
compared to Nugent score as the gold standard test, diagnosis of BV done by Amsel’s 
criteria has a clinical sensitivity of 97% and specificity of 90% (Simoes et al. 2006). 
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BV can also be defined based on the phylogenetic characteristics of a sample 
determined by sequences obtained using deep sequencing, which is referred to as a 
‘molecular definition’ of BV. For instance, Schellenberg et al. (2011b) defined samples 
as ‘BV negative’ as ones with high abundance of Lactobacillus and ‘BV positive’ 
samples as those with lowest abundance of Lactobacillus. Samples defined as 
‘intermediate’ were dominated by Gardnerella. Schellenberg et al. (2011b) also defined 
an outlier group dominated by E. coli. The presence of specific sequences such as that of 
BV associated bacteria (BVAB1 closely related to Eubacterium spp., BVAB2 and 
BVAB3 closely related to Clostridium stercorarium) has been strongly associated with 
the diagnosis of BV (Fredricks et al. 2005; Haggerty et al. 2009). Prevotella spp., 
BVAB1 and Dialister micraerophilus have been related to the clinical criterion of 
positive whiff test (amine odor upon addition of 10% KOH to vaginal discharge) 
(Srinivasan et al. 2012). Another important bacterial species described as a strong 
predictor of BV by culture independent studies is Megasphaera type 1 (Fredricks et al. 
2007; Shipitsyna et al. 2013). Though these species are described in the literature as 
being strong predictors of BV, none of them are currently being used in any assays for 
diagnosis of BV. 
BV in many women is often a recurrent or chronic condition. As already 
described, BV is mostly characterized by an overgrowth of predominantly anaerobic 
organisms like G. vaginalis, Prevotella spp., Peptostreptococcus, Atopobium and 
Mobiluncus spp. in the vagina leading to a replacement of lactobacilli. BV-associated 
organisms produce many virulence factors: mucinases, cytolysins, prolidases, 
siderophores, human-lactoferrin binding proteins, lipases, phospholipases and proteolytic 
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carboxylase enzymes. BV-associated organisms are capable of breaking down vaginal 
peptides into amines using the proteolytic enzymes and releasing amines such as 
methylamine, isobutylamine, putrescine, cadaverine, histamine, tyramine, and 
phenethylamine into the vaginal fluid increasing its pH (Cruden and Galask 1988; Sobel 
2000; Wolrath et al. 2001). Amines in turn cause vaginal transudation and squamous 
epithelial cell exfoliation, leading to the vaginal discharge that is a typical clinical 
symptom of women with BV.  
Even after decades of research, the aetiology of BV is still poorly understood. 
Major theories on the causes of BV revolve around G. vaginalis, lactobacilli, 
bacteriophages and the genetic predisposition of the host (Turovskiy et al. 2011). 
However, risks associated with BV are well documented. Many case control and cohort 
based studies have documented that BV increases the risk of preterm birth (Goldenberg et 
al. 2008; Hillier et al. 1995; Oleen-Burkey and Hillier 1995). BV is also implicated in 
causing pelvic inflammatory disease (PID). Anaerobic species associated with BV such 
as Prevotella bivia, other Prevotella species, and Peptostreptococcus species have been 
isolated from the fallopian tube tissue of women with acute PID (Soper et al. 1994). BV 
is also associated with post-abortion PID, post-hysterectomy cuff cellulitis, post-
Caesarian endomyometritis as well as with cervical intraepithelial neoplasia (Sobel 
2000). 
Both symptomatic or “asymptomatic” BV (asymptomatic being defined as cases 
with high Nugent score, but with no clinical symptoms) are associated with both obstetric 
complications and gynecologic complications (Gibbs 2007). However, treatment of 
asymptomatic BV is recommended only in cases of women who are either at high risk for 
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preterm delivery or undergoing surgical procedures (2002). 
The most common treatment options for BV include prescription medications 
such as oral metronidazole or clindamycin, intravaginal metronidazole gel or intravaginal 
clindamycin cream. There are other options available such vaginal hormone replacement 
treatment (Vagifem) and ‘over-the-counter’ treatments (Powell 2013). Other alternatives 
include triple-sulfa creams, erythromycin, tetracycline, acetic acid gel as well as many 
types of vaginal douches. Due to their poor efficacy, none of the above described 
alternatives have become popular in treating BV. Currently, the most effective treatment 
for BV is oral metronidazole therapy. Intravaginal metronidazole gel and intravaginal 
clindamycin cream have also been shown to be as effective as oral metronidazole (Ferris 
et al. 1995). However, about 30% of patients who initially responded to oral 
metronidazole therapy experience recurrence of symptoms within three months. The 
reason for recurrence is still poorly understood. Some of the explanations provided are 
the possibility of re-infection, presence of metronidazole resistant organisms 
(Mycoplasma hominis, Mobiluncus curtisii), the possible development of resistance by 
previously sensitive species (G. vaginalis) and protection of BV associated microbes 
through biofilms (Sobel 2000; Spiegel 1991). Effective treatment can be achieved for 
individuals by choosing optimal doses and varying treatment lengths, but tailored 
treatment approaches are required for some cohorts of women, which presents a 
significant clinical challenge (Koumans et al. 2002). 
1.4 Gardnerella vaginalis 
Gardnerella vaginalis is considered as one of the most important microorganisms 
as far as the genital tract health of women is concerned. It is sometimes referred to as the 
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hallmark organism of BV. This microbe has been studied for the past 65 years. First 
isolated in 1953 by Leopold (1953), initially named as Haemophilus vaginalis by 
Gardner and Dukes in 1955 (1955) and later as Corynebacterium vaginale by Zinnemann 
and Turner (1963), G. vaginalis was an organism classified with great difficulty. Due to 
its unusual cell wall, it required intense study employing methods such as DNA-DNA 
hybridization, and electron microscopy to establish that this organism was distinct from 
previously characterized Gram positive or Gram negative genera (Greenwood and 
Poickett 1980; Piot et al. 1980). The name ‘Gardnerella’ was eventually proposed for 
this genus by Greenwood and Pickett (1980), supported by Piot et al. (1980). G. vaginalis 
remains the only species in the genus. 
G. vaginalis (phylum Actinobacteria) is a fastidious, β-haemolytic, catalase-
negative, non-capsulated, immobile pleomorphic rod. The Gram stain for G. vaginalis 
varies from Gram negative to Gram positive and hence is often described as 'Gram 
variable'. Ultrastructural examination of G. vaginalis ATCC 14018T generated by Reyn et 
al. (1966) indicated well defined septa formed before cell division, which is indicative of 
Gram positive cells. Another characteristic feature of a Gram positive cell wall exhibited 
by G. vaginalis is the absence of diaminopimelic acid and lipopolysaccharide in the cell 
wall (Sadhu et al. 1989). Characteristics suggestive of a Gram negative cell wall of G. 
vaginalis are its amino acid composition, laminated structure and low peptidoglycan 
content (Catlin 1992; Piot et al. 1980). 
 G. vaginalis is routinely isolated from women with BV but is also present in 
women without BV. However, quantitative polymerase chain reaction (PCR) studies 
indicate high levels of G. vaginalis associated with BV diagnosis (Menard et al. 2008; 
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Zariffard et al. 2002). Other bacteria associated with BV such as genital mycoplasmas 
and strict anaerobes species such as BVAB1, BVAB2, BVAB3, Atopobium, Leptotrichia, 
Megasphaera, and Prevotella are isolated at varying rates from women with BV. Many 
conceptual model based theories exist on how G. vaginalis with the aid of its many 
virulence factors adheres to the vaginal epithelium of the host and successfully competes 
with the microbiota present in the vagina leading to pathogenesis of BV. G. vaginalis 
requires virulence factors for accomplishing three functions in the vagina: adherence to 
host receptor sites, production of cytotoxins specific for host cells, and biofilm formation. 
Some of the virulence factors produced by G. vaginalis include vaginolysin (Gelber et al. 
2008), sialidase (Santiago et al. 2011b), bacteriocins (Teixeira et al. 2010), hemolysin 
(Cauci et al. 1993), and human lactoferrin binding protein (Jarosik and Land 2000). 
Vaginolysin is a human specific cholesterol-dependent cytolysin (CDC) that has the 
ability to form pores in target cell membranes resulting in lysis of target host cells 
(Gelber et al. 2008). Sialidase is a mucinase, specifically a neuraminidase that cleaves 
alpha-ketosidic linkages between glycosyl residues of glycoproteins, glycolipids and 
sialic acids. Hemolysin, a 59 kDa cytolysin characterized in G. vaginalis, is specific to 
human erythrocytes and is able to lyse the cells (Cauci et al. 1993). G. vaginalis  is 
known to produce biofilm and biofilms produced by G. vaginalis  are demonstrated to be 
present on the surface of the vaginal epithelium in women with BV (Patterson et al. 2010; 
Swidsinski et al. 2005). Biofilms produced by G. vaginalis have been implicated in 
sexual transmission of BV (Swidsinski et al. 2010). However, the protein factors 
involved in production of biofilms are still incompletely characterized. 
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 As previously described, the Nugent score based on Gram stain is used to 
diagnose BV, and G. vaginalis abundance in the sample is one major factor determining 
the Nugent score. However, a high Nugent score does not always correspond to the 
presence of clinical symptoms. As more studies of vaginal microbiomes are conducted, 
G. vaginalis is becoming recognized as a heterogeneous group of organisms, and is also 
being accepted as a part of normal vaginal microbiota. Studies report that organisms 
grouped as G. vaginalis are phenotypically very diverse (Benito et al. 1986; Piot et al. 
1984). G. vaginalis has been classified into eight biotypes based on the presence of β-
galactosidase, lipase and hippurate hydrolysis ability (Piot et al. 1984), whereas Benito 
and associates have identified seventeen biotypes (Benito et al. 1986). Piot biotype 5 was 
found to be one of the most frequently isolated biotypes from healthy women 
(Aroutcheva et al. 2001). The same study reports Piot biotypes 7 and 8 as the most 
frequently isolated from BV patients with isolation rates of 32% (for biotype 7) and 20% 
(for biotype 8) (Aroutcheva et al. 2001). Interestingly, Piot biotype 5 has also been 
reported to be associated with BV (Benito et al. 1986). Some biotypes of G. vaginalis 
from both typing schemes have been associated with BV (Aroutcheva et al. 2001; 
Numanovic et al. 2008). Genotypic heterogeneity defined by different Gardnerella-like 
sequences detected in previous cpn60 sequence libraries (Hill et al. 2005a; Schellenberg 
et al. 2009a) of vaginal samples has also been described. Phenotypic and genotypic 
heterogeneity of the diverse group of organisms grouped under the binomial 'Gardnerella 
vaginalis' needs to be better characterized and sub-categories must be resolved to permit 
the sub-classification of G. vaginalis and to understand if clinical significance can be 
associated with the sub-categories if resolved.  
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1.5 Mollicutes  
Species of the class Mollicutes isolated from the urogenital tract of humans 
include Mycoplasma fermentans, Mycoplasma genitalium, Mycoplasma hominis, 
Mycoplasma penetrans, Mycoplasma primatum, Mycoplasma spermatophilum, 
Ureaplasma parvum, and Ureaplasma urealyticum. Mollicutes are well known to live as 
parasites on or in various animal and plant tissues. They are typically small in size (0.2 - 
0.3 µm) and possess relatively very small genomes. For example, Mycoplasma 
genitalium has a genome size of 580 kb. 
Genital mycoplasmas and ureaplasmas are strongly associated with BV, and with 
other female genital infections such as vaginitis, cervicitis, and PID. Review of the 
literature suggests that four Mollicutes species are significant predictors of genital tract 
health of women: Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma 
urealyticum and Ureaplasma parvum.  Mycoplasma hominis is an important organism in 
this group that is believed to be involved in BV, infertility, miscarriage, respiratory 
distress in newborns, and neonatal meningitis (Schlicht et al. 2004; Taylor-Robinson 
1996). Ureaplasmas are associated with preterm labour, decreased sperm motility, 
intrauterine infection, lung disease, and neonatal pneumonia (Waites et al. 2005). These 
organisms are regularly detected in vaginal samples using culture-based methods or 
species-specific PCR. 
Despite their apparent clinical significance and high prevalence in women of 
various health status, mycoplasmas and ureaplasmas are rarely detected in metagenomic 
studies, especially those using next-generation sequencing based methods. One possible 
explanation for the absence or under-representation of Mollicutes in metagenomic 
 16 
libraries is that the primers used to amplify the target gene (usually 16S rRNA) are biased 
against amplification from certain taxa, including Mycoplasma and Ureaplasma 
(Hummelen et al. 2010). Mollicutes have not been detected in cpn60 libraries from the 
vaginal microbiome (Hill et al. 2005a; Schellenberg et al. 2009a). This is due to the 
absence of the cpn60 target gene, along with several other genes previously considered 
"essential", in virtually all Mycoplasma and Ureaplasma. The exception is Mycoplasma 
genitalium, which contains a cpn60 gene, but still has not been detected in studies. The 
capability of detecting and identifying Mollicutes in samples from the vaginal 
microbiome is essential to our goal of achieving comprehensive profiling methods for the 
evaluation of vaginal microbial environments. Methodologies to detect Mycoplasma 
hominis, Mycoplasma genitalium, Ureaplasma parvum, Ureaplasma urealyticum and any 
other significant Mollicutes in vaginal samples need to be developed and validated by 
adopting and modifying methods already established for their detection in tissue culture 
and the identification of cultured isolates. 
1.6 Preterm premature rupture of membranes 
Preterm birth is one of the foremost perinatal challenges worldwide that often 
results in serious implications for the mother and the baby. Preterm birth overburdens 
medical facilities and systems in respective countries. The preterm birth rate in North 
America is about 10.6% and the annual cost of care for preterm infants in the United 
States alone is greater than $26 billion (Christopher et al. 2009). 
In pregnancy, disturbances of the vaginal microbial community are associated 
with the release of inflammatory cytokines and chemokines (Cauci et al. 2002). 
Microbial endotoxins and cytokines produced by the host stimulate the production of 
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prostaglandins and matrix-degrading enzymes (Roberton et al. 2005), which can lead to 
the stimulation of uterine contraction or weakening of the amniotic membrane and 
eventually its rupture (Mascagni and Miller 2004). Preterm rupture of membrane 
(PROM) is defined as rupture of membrane/amniotic sac before the beginning of labour. 
When PROM occurs before 37 weeks of pregnancy, it is called preterm premature 
rupture of membrane (PPROM), which can lead to preterm birth. Women having 
PPROM can be categorized into three groups based on the outcome of time of delivery 
following membrane rupture: women who deliver immediately following membrane 
rupture (< 48 hrs), women with extended latencies between 48 hrs and ≤ 7 days following 
membrane rupture, and women that deliver > 7 days following membrane rupture. 
However, the factors that determine the duration of latency are not well understood. 
Among the major pathophysiological pathways contributing to PPROM and the 
outcomes of premature birth are abnormal vaginal microbiota and associated maternal 
infection and inflammatory response (Green et al. 2005). Though there is limited 
understanding of the pathophysiological pathways contributing to the etiology of preterm 
birth, intrauterine infection resulting from an abnormal/unhealthy vaginal microbial 
community is thought to play a significant role in triggering PPROM, especially at lower 
gestational ages. 
Microbes such as Gardnerella, Mycoplasma, Ureaplasma, Mobiluncus and other 
aerotolerant and anaerobic organisms are associated with BV and other genital tract 
issues. Intrauterine infection due to microbes present in vagina is considered an important 
risk factor for premature preterm rupture of membrane (PPROM). Many virulence factors 
from BV-associated organisms have been characterized (Wiggins et al. 2001) including 
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mucinases, cytolysins, prolidases, siderophores, human-lactoferrin binding proteins, 
lipases, and phospholipases.  
Mucinases are hydrolyzing enzymes secreted by microorganisms to lyse and 
degrade vaginal mucus. Mucinases have been recognized for a long time, but only some 
like sialidases have been studied extensively. Other known mucinases in the human 
vagina include glycosidases, proteases, and sulfatases. Mucinases are produced mostly by 
anaerobic bacteria and probably aid in their successful colonization during BV by 
enabling adherence to vaginal epithelial cells. Wiggins et al. (2001) suggested that 
glycosidase enzymes result in cervical mucin degradation, enabling colonization of the 
upper reproductive tract and chorioamnionitis in pregnant women. Sialidases are 
relatively well-characterized enzymes with mucinase and neuraminidase activity that 
have been described to affect the collagen synthesis ability of fibroblasts (Aalto et al. 
1974). Sialidase activity of vaginal fluid is highly correlated with BV, and is used as a 
marker for diagnosing BV (Briselden et al. 1992; Cauci et al. 2005; Shujatullah et al. 
2010). Collagen content of the fetal membrane is directly responsible for the tensile 
strength of the membrane. Decreased collagen content, altered collagen structure and 
increased collagenolytic activity are proposed to be associated with PPROM (Epstein et 
al. 1998). Prolidases and proteases are also linked to collagen metabolism and prolidases 
have been proposed to predict preterm birth in combination with pH and sialidase (Cauci 
et al. 2005).  
Cytolysins, pore-forming exotoxins that lyse animal cells, are important virulence 
factors produced by many Gram negative bacteria (Welch 1991). Vaginolysin is one such 
human-specific cholesterol dependent cytolysin, characterized in G. vaginalis (Gelber et 
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al. 2008). Prolidases are capable of modulating the activity of immune factors and high 
levels of prolidase were inversely correlated with the host’s ability to elicit an appropriate 
immune response (Schoonmaker et al. 1991; Vanhoof et al. 1995). One of the ways that 
intrauterine infection can cause preterm membrane rupture is by eliciting an immune 
response that increases the production of prostaglandins, in turn causing membrane 
rupture.  
Phospholipases are enzymes that can degrade phospholipids present on the cell 
surface. Phospholipase A2 is reported to be able to release arachidonic acid from 
membrane phospholipids of the amnion. Arachidonic acids are precursors to 
prostaglandins. During an immune response, cytokines in the uterus produce 
cyclooxygenase II, which can convert arachidonic acid to prostaglandins. Prostaglandins 
induce uterine contractions and stimulation, which can lead to membrane rupture. 
Phospholiapase A2 activity is reported to be higher in pregnant women with BV (Jones 
and Al-Mushrif 1997) .  
Despite a growing understanding of specific microbial virulence factors and the 
pathophysiology of PPROM, there is still little understanding of what kinds of vaginal 
microbial communities indicate a risk of PPROM or predict outcomes following 
PPROM. This is due to a number of challenges faced in this area of research. Major 
challenges include overly simplistic diagnostic tools for detecting abnormal vaginal 
microbiota, and failure to discriminate BV from other conditions such as aerobic 
vaginitis. Research is also significantly impeded by difficulty in obtaining samples from 
women with PPROM due to the unpredictability of PPROM and the complex clinical 
aspects of this potentially devastating event. Another important challenge is the 
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uniqueness of vaginal microbiomes. The Human Microbiome Project claims that every 
person has a unique microbial community on the skin (Fierer et al. 2010). Researchers in 
the vaginal microbiome area report difficulty in identifying "core" organisms associated 
with the microbiome (Ravel et al. 2011), suggesting that every woman may have a 
unique vaginal microbiome with varying richness and diversity of taxa. A high-resolution 
picture of the vaginal microbiome and the ability to resolve its members to the species 
level, that in turn can be linked to differences in their genotypic and phenotypic 
properties is needed to decipher any signature pattern that might help clinicians predict 




The overall objective of this research project is to obtain a better understanding and 
higher resolution view of the vaginal microbial community that can be applied to 
defining the relationship of this community to health or disease. Specific objectives that 
follow are: 
• Determine if G. vaginalis cpn60 sequence diversity observed in metagenomic 
studies of vaginal microbiota represents phenotypically distinct subpopulations.  
• Comprehensively define G. vaginalis subgroups through comparative genomics, 
proteomics, detection of putative virulence factors and identification of 
biomarkers. 
• Investigate the association of vaginal microbiome structure with maternal and 
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Second Chapter Transition 
In this manuscript I addressed the first objective of the project, which was to resolve 
genotypic and phenotypic heterogeneity of G. vaginalis, a hallmark group of organisms 
associated with BV. I investigated whether biotypes defined by the earliest and most 
popular biotyping scheme (Piot biotyping (Piot et al. 1984)) are consistent with 
genotypes described for the genus. The ultimate motivation behind resolving the 
heterogeneity is to understand any clinical significance that may be associated with 
resolved groups. Hence, distribution of the resolved subgroups was investigated in a 
cohort of Kenyan women grouped into three based on their Nugent score: normal, 




Bacterial vaginosis (BV), characterized by a shift of the vaginal microbiota from a 
Lactobacillus dominated community to a dense biofilm containing a complex mixture of 
organisms, is an important risk factor in poor reproductive health outcomes. The Nugent 
score, based on Gram stain, is used to diagnose BV and G. vaginalis abundance in the 
sample is one factor determining Nugent score. A high Nugent score is indicative of BV 
but does not always correspond to the presence of clinical symptoms. G. vaginalis is 
recognized as a heterogeneous group of organisms, which can also be part of the normal, 
healthy vaginal microbiome. In addition, asymptomatic BV and non-Gardnerella types of 
BV are being recognized. In an attempt to resolve the heterogeneous group of G. 
vaginalis, a phylogenetic tree of cpn60 universal target sequences from G. vaginalis 
isolates was constructed that indicates the existence of four subgroups of G. vaginalis. 
This subdivision, supported by whole genome similarity calculation of representative 
strains using JSpecies, demonstrates that these subgroups may represent different species. 
The cpn60 subgroupings did not correspond with the Piot biotyping scheme, but did show 
consistency with ARDRA genotyping and sialidase gene presence. Isolates from all four 
subgroups produced biofilm in vitro. We also investigated the distribution of G. vaginalis 
subgroups in vaginal samples from Kenyan women with Nugent scores consistent with 
BV, Intermediate and Normal microbiota (n=44). All subgroups of G. vaginalis were 
detected in these women, with a significant difference (z = -3.372, n = 39, p = 0.001) in 
frequency of G. vaginalis subgroup B between BV and Normal groups. Establishment of 
a quantifiable relationship between G. vaginalis subgroup distribution and clinical status 
could have significant diagnostic implications.  
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2.2 Introduction 
Gardnerella vaginalis, first isolated by Leopold in 1953 (Leopold 1953), has long 
been recognized in vaginal samples and has been identified by several names, including 
Haemophilus vaginalis by Gardner and Dukes in 1955 (Gardner and Dukes 1955). 
Further characterization based on metabolic requirements and Gram staining led to its 
reclassification as Corynebacterium vaginale (Zinnemann and Turner 1963). The 
proposal to create the genus Gardnerella and allocation of Corynebacterium vaginale and 
Haemophilus vaginalis to this new taxon as Gardnerella vaginalis was put forward by 
Greenwood and Pickett (Greenwood and Poickett 1980), based on a taxonomic study that 
utilized DNA-DNA hybridization, biochemical analysis of the cell wall, and electron 
microscopy. 
G. vaginalis is strongly associated with BV, and is one of the most frequently 
isolated bacteria from women with symptoms of BV (Demba et al. 2005a, b; Hillier et al. 
1991; Schellenberg et al. 2011b). Abundance of G. vaginalis in vaginal samples has also 
been associated with infertility and preterm labour (Menard et al. 2010). G. vaginalis has 
also been isolated from urine and blood and is associated with bacteremia, osteomyelitis 
and  cervical cancer (Graham et al. 2009; Johnson and Boustouller 1987; Mikamo et al. 
1999). However, recent studies of vaginal microbiota indicate that G. vaginalis can also 
be a part of the vaginal microbiota in clinically healthy women (Hill et al. 2005a; 
Schellenberg et al. 2011b; Tosun et al. 2007).  
G. vaginalis is recognized as a diverse taxon, both phenotypically and 
genotypically (Benito et al. 1986; Piot et al. 1984; Tosun et al. 2007). Eight biotypes of 
G. vaginalis have been identified by Piot et al. based on the presence of β-galactosidase, 
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lipase and hippurate hydrolysis activities (Piot et al. 1984), whereas Benito et al. 
identified seventeen biotypes based on these characteristics in addition to fermentation of 
xylose, arabinose and galactose (Benito et al. 1986). Phenotypic diversity within G. 
vaginalis has also been described in terms of virulence factors, particularly production of 
sialidase (Santiago et al. 2011b) and formation of biofilms (Swidsinski et al. 2010). 
Genetic heterogeneity within G. vaginalis has been demonstrated using amplified 
ribosomal DNA restriction analysis (ARDRA) (Ingianni et al. 1997). Santiago et al. 
(Santiago et al. 2011b), identified three ARDRA genotypes of G. vaginalis, of which 
only two genotypes (genotypes 1 and 3) produced sialidase. However, like biotyping 
schemes, ARDRA can only be performed on isolates.  
Genotype diversity is apparent in whole genome studies and in metagenomic 
studies of the human vaginal microbiome based on 16S rRNA (Hummelen et al. 2010) or 
cpn60 (Hill et al. 2005a; Schellenberg et al. 2011b). Hummelen et al. (2010) reported the 
presence of four types of G. vaginalis sequences differing by a single nucleotide within 
the 16S rRNA V6 region. Four clusters of G. vaginalis sequences, ranging between 89 
and 100% sequence identity to the type strain (ATCC 14018T), were observed in a cpn60-
based study of clinically healthy women by Hill et al. (2005a) and followed up in a larger 
study by Schellenberg et al. (2011b).  
Previous work by our research group has demonstrated that cpn60 universal target 
sequences can resolve phenotypically distinct strains or ecotypes within an intestinal 
microbial community, and that these sequences are also excellent predictors of whole 
genome sequence relationships (Verbeke et al. 2011; Vermette et al. 2010). The gene 
encoding the universal 60 kDa chaperonin protein (cpn60) is an established target for 
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detection and identification of microorganisms, as well as gene-based metagenomic 
studies of complex microbial communities, including the vaginal microbiome (Chaban et 
al. 2012; Desai et al. 2012; Desai et al. 2009; Dumonceaux et al. 2006a; Dumonceaux et 
al. 2006b; Fernando et al. 2010; Hill et al. 2005a; Hill et al. 2005b; Hill et al. 2002; 
Schellenberg et al. 2009a; Schellenberg et al. 2011a; Schellenberg et al. 2011b). An 
approximately 555 bp region corresponding to nucleotides 274-828 of the E. coli cpn60 
gene can be amplified with degenerate, universal PCR primers (Goh et al. 1996; Hill et 
al. 2006b). This universal target (UT) region is phylogenetically informative, providing 
more discriminating power than 16S rRNA to differentiate organisms, even at the sub-
species or strain level (Blaiotta et al. 2008; Brousseau et al. 2001; Goh et al. 2000; Hill et 
al. 2006a; Hung et al. 2010; Jian et al. 2001; Minana-Galbis et al. 2009; Sakamoto and 
Ohkuma 2010; Sakamoto et al. 2010; Vermette et al. 2010). A highly curated reference 
database of chaperonin sequences, cpnDB, supports cpn60 based applications (Hill et al. 
2004).  
Given the observed phenotypic diversity (especially virulence factors), genotypic 
diversity, and the presence of G. vaginalis in women regardless of clinical status, it is 
critical to improve our understanding of the clinical significance of these different strains. 
In order to accomplish this most effectively and to lay the foundation for the development 
of more informative diagnostic tools for women’s health, direct culture-independent 
analysis of vaginal samples, exploiting a genetic target that facilitates robust resolution is 
required.  
The objective of the current study was to investigate if previously observed cpn60 
based subgroups of G. vaginalis are consistent with other (phenotypic) classification 
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systems and/or available whole genome sequences, and to investigate the distribution of 
cpn60 defined subgroups of G. vaginalis in women with and without BV. Our results 
demonstrate that the cpn60 universal target sequence differentiates distinct subgroups 
within G. vaginalis and that only one of these subgroups (Subgroup B: Piot biotype 5, 
sialidase positive and ARDRA genotype 1) was found to be significantly more abundant 
in women with BV (high Nugent score) than women with normal vaginal microbiota in a 
retrospective analysis of metagenomic profiles of Kenyan women. 
2.3 Materials and Methods 
Bacterial isolates 
G. vaginalis ATCC 14018 (type strain) and ATCC 49145 were obtained from the 
American Type Culture Collection (Manassas, VA). Eight additional strains were isolated 
from Kenyan (N170, N165, N160, N158, N153, N148, N144, N143, N137, N134, N101, 
and N72) or Canadian (W11) women as described previously (Schellenberg et al. 2011b). 
G. vaginalis isolates were cultured using the following media: ATCC #1685 broth (with 
or without 1% (w/v) glucose), Brain Heart Infusion broth (BHI) with 1% (w/v) glucose, 
egg yolk agar (Piot et al. 1984) and Columbia agar with 5% sheep blood (BD, 
Mississauga, ON). The GasPak EZ Pouch System (BD, Mississauga, ON) was used to 
provide anaerobic conditions. 
DNA extraction and PCR 
DNA was extracted from isolates using a phenol-chloroform extraction method 
and was stored at -20 °C. Primers used in the study are listed in Table 2.1. cpn60 UT 
PCR amplicons were produced for direct sequencing, using universal primers H729 and 
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H730 as described previously (Hill et al. 2006b). Primers JH0315 and JH0316 were 
designed based on the 16S rRNA sequence from G. vaginalis ATCC 14018. 
Amplification with these primers was carried out by incubating the reactions at 94 °C for 
3 minutes, followed by 40 cycles of 94 °C for 30 sec, 52 °C for 1 min and 72 °C for 90 
sec, and completed with a final extension of 10 min at 72 °C. Sialidase gene presence 
was assessed by amplifying the sialidase gene using primers GVSI forward and GVSI 
reverse (Santiago et al. 2011b). Vaginolysin gene sequences were amplified using 
primers V1 and V2 as previously described (Gelber et al. 2008). 
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Table 2.1. Primers used in the study. 
Primer name Sequence (5'-3') Reference 
H729 CGC CAG GGT TTT CCC AGT CAC GAC GAI III 
GCI GGI GAY GGI ACI ACI AC 
(Hill et al. 2006b) 
   
H730 AGC GGA TAA CAA TTT CAC ACA GGA YKI YKI 
TCI CCR AAI CCI GGI GCY TT 
(Hill et al. 2006b) 
   
JH0315 ATT CTG GCT CAG GAT GAA  This study 
   
JH0316 GCT ACC TTG TTA CGA CTT AG This study 
   
GVSI forward GAC GAC GGC GAA TGG CAC GA (Santiago et al. 2011b) 
   
GVSI reverse AGT CGC ACT CCG CGC AAG TC (Santiago et al. 2011b) 
   
V1 ATG CAG CGA AGC ATG CCA TGC (Gelber et al. 2008) 
   
V2 TCA GTC GTT CTT TAC AGT TTC (Gelber et al. 2008) 
   
GV10F GGT TCG ATT CTG GCT CAG (Santiago et al. 2011b) 
   




Phenotyping of G. vaginalis isolates 
Representative G. vaginalis isolates with unique cpn60 sequences were 
phenotyped using the Piot typing scheme using assays for hippurate hydrolysis, β-
galactosidase and lipase activity as described previously (Piot et al. 1984). Lactobacillus 
crispatus was used as a negative control for the lipase assay. G. vaginalis ATCC 14018T 
was used as a positive control for all biochemical assays. 
Biofilm formation 
Isolates of G. vaginalis were cultured from -80 °C stocks for 72 hrs, and 
subcultured for 48 hrs on Columbia sheep blood agar plates anaerobically at 37 °C. A 
loopful of culture for each isolate was used to inoculate 4 ml of either ATCC broth #1685 
supplemented with 1% (w/v) glucose or Brain Heart Infusion supplemented with 1% 
(w/v) glucose (BHIG) and incubated anaerobically for 48 hrs at 37 °C. Broth cultures 
were diluted 1:100 in media and 200 µl of diluted culture was added to individual wells 
of a 96-well tissue culture plate and incubated anaerobically for 48 hrs at 37 °C. 
Qualitative assessment of biofilm formation was done by washing off the planktonic cells 
and staining the wells with 1% crystal violet solution to visualize any biofilm. 
ARDRA genotyping 
G. vaginalis isolates were genotyped using amplified rDNA restriction analysis 
(ARDRA) (Ingianni et al. 1997; Santiago et al. 2011b). Full-length 16S rRNA gene 
sequences were amplified using primers GV10F and ωMB (Table 2.1). PCR products 
were purified (QIAquick PCR Purification Kit, Qiagen, Inc., Toronto, ON) and subjected 
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to overnight restriction digestion using TaqI (Life Technologies, Inc., Burlington, ON). 
The digestion products were resolved on a 1.5% agarose gel at 140 volts for 2 hrs. In 
silico ARDRA was performed for some strains for which only published genome 
sequence information was available (not the isolates themselves) by extracting full length 
16S rRNA gene sequences from published whole genome sequences and then restricting 
the sequence using the program remap within the EMBOSS software suite (Rice et al. 
2000). 
Sequence sources  
Published genome sequences of G. vaginalis used in the study, either completed 
or in progress, were downloaded from NCBI’s Genome database. The metagenomic 
cpn60 sequences and cpn60 UT sequences of G. vaginalis isolates used were from a 
previously published study of vaginal microbiota of commercial sex workers in Kenya 
(Schellenberg et al. 2011b).  
Phylogenetic analysis 
cpn60 UT sequences obtained from whole genome sequences of G. vaginalis 
reference strains or amplified from cultured clinical isolates (Schellenberg et al. 2011a) 
were used to construct a phylogenetic tree, using Alloscardovia omnicolens CCUG 34444 
as a root. Sequences were aligned using ClustalW (gap opening penalty = 10, gap 
extension penalty = 0.10) (Thompson et al. 1994), followed by utilization of the Phylip 
software package (Felsenstein 1993) to calculate a distance matrix using dnadist and 
construct a tree using neighbor. The final tree was obtained from the bootstrapped 
consensus of 100 trees and was visualized using Dendroscope (Huson et al. 2007).  
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Statistical analysis 
All statistical analyses were done using SPSS Statistics, version 19.0. For the 
analysis of assignment of assembled reads of Nairobi metagenomic data set to G. 
vaginalis subgroups, one-way ANOVA was done, followed by Post-hoc analysis by 
Tukey’s test. Statistical analysis for the distribution of G. vaginalis subgroups in Nairobi 
women was done by Kruskal-Wallis H test, followed by Mann-Whitney U test. 
2.4 Results 
cpn60-based resolution of G. vaginalis subgroups 
A phylogenetic tree of G. vaginalis cpn60 UT sequences is shown in Figure 2.1A. 
This tree was used to select landmark sequences for further comparisons and for 
subgrouping of G. vaginalis metagenomic sequences. The discreteness of the subgroups 
was further supported by demonstration of a bimodal distribution of pairwise distances 
(inter- and intra-subgroup) between strains (Figure 2.1B). The four subgroups resolved 
were designated A, B, C and D and two representative sequences from each subgroup 
were selected as representatives to capture the maximum phylogenetic distance 




Figure 2.1. cpn60 UT sequence-based subgroups of G. vaginalis.  
A. Phylogenetic tree of G. vaginalis-like cpn60 UT sequences comprising four distinct clades: A, B, C and 
D. Bootstrap values for each node are indicated. 101, 315-A, 41V, 409-05, 5-1, AMD, ATCC 14018T, 
ATCC 14019, and HMP9231 are G. vaginalis isolates with whole genome sequence information available 
in Genbank (Accession numbers AEJD00000000, AFDI00000000, AEJE00000000, CP001849, 
ADAN00000000, ADAM00000000, ADNB00000000, CP002104 and CP002725 respectively). Isolates 
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with names starting with “N” are isolates from Kenyan women from Schellenberg et al. (2011a). W11 was 
isolated from a Canadian woman (Schellenberg, Unpublished). Sequences highlighted in red were used as 
representatives of the subgroups in the distribution analysis of metagenomic sequence data. B. Pairwise 
distances for the 26 G. vaginalis cpn60 UT sequences included in the phylogenetic analysis. Distances for 




Whole genome, cpn60 and 16S rRNA comparisons 
Whole genome similarity calculations of representative strains of G. vaginalis for 
which there was either complete or partial genome sequence data available were 
calculated with JSpecies (Table 2.2). Within subgroups, pairwise Average Nucleotide 
Identity by MUMmer (ANIm) values were >95% and cpn60 identities were ≥96%, while 
between subgroups ANIm values were <90% and cpn60 identities were ≤92%. Pairwise 
identities based on16S rRNA were all 98-100%. Pairwise cpn60 and 16S rRNA sequence 
identities for representative isolates with unique cpn60 sequences are shown in Table 2.3. 
The pairwise sequence identity for cpn60 gene sequences and 16S rRNA gene sequences 
for isolates within G. vaginalis subgroups are >96% and >97%, respectively. Between G. 
vaginalis subgroups, pairwise identities ranged between 87% and 93% for cpn60 
sequences and 97% and 100% for 16S rRNA sequences. 
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Table 2.2. ANIm (first row), cpn60 UT sequence identity (second row) and 16S rRNA sequence 
identity (third row) for representatives of G. vaginalis subgroups A, C and D, for which whole 
genome sequence data was available. No whole genome sequence is available for a subgroup B strain. 
  A C D 




315-A HMP9321 101 
 
409-05 
95.86 98.2 89.09 88.97 89.13 88.85 89.1 88.56 
A 
97 99 88 90 88 88 88 91 
99 100 98 98 98 98 98 99 
AMD 
 95.7 89.06 88.64 89 88.98 89.59 88.51 
  97 89 90 89 88 89 91 
  99 98 98 98 98 98 99 
5-1 
   89.31 88.89 89.29 88.96 89.96 88.91 
    88 91 88 88 88 91 




     95.91 99.79 98.19 98.35 88.29 
C 
      96 100 99 99 92 
      99 100 100 100 98 
41V 
       95.87 96.04 96.07 88.66 
        96 96 96 92 
        99 99 99 98 
ATCC 
14018 
         98.13 98.27 88.22 
          99 99 92 
          100 100 98 
315-A 
           98.38 88.45 
            99 92 
            100 98 
HMP9321 
             89.19 
              92 




Table 2.3. Pairwise sequence identity of cpn60 (first row of each column) and full-length 16S rRNA 
(second row) for G. vaginalis isolates. ND = Not done. Only representative study isolates with unique 
cpn60 sequences are included. 



































































409-05 99 98 97 99 98 90 87 87 88 90 89 90 88 88 88 88 90 91 
99 99 99 100 99 ND  99 99 98 98 ND 98 98 98 98 98 99 99 
N158   98 97 100 98 90 87 87 88 90 89 91 88 88 88 88 90 91 
  99 99 99 99 ND  99 99 98 98 ND  98 98 98 98 98 99 99 
N134     97 98 98 89 87 88 88 90 89 90 88 88 88 88 90 91 
    99 99 99 ND  99 99 98 98  ND 98 98 98 98 98 99 99 
AMD       97 97 89 87 88 89 91 89 90 89 88 89 89 90 91 
      99 100 ND  99 99 98 98  ND 98 98 98 98 98 99 99 
5-1         98 90 87 87 88 90 89 91 88 88 88 88 90 91 
        99  ND 99 99 98 98 ND  98 98 98 98 98 99 99 
N137           89 87 88 89 91 90 91 89 89 89 89 90 91 
          ND  99 99 98 98  ND 98 98 98 98 98 99 99 
N156             96 96 88 90 89 89 88 89 89 88 88 88 
            ND  ND ND ND ND ND ND ND ND ND ND ND 
N153               98 89 90 89 89 89 90 89 89 88 88 
              99 99 99 ND  99 99 99 99 99 99 99 
N144                 89 91 90 90 89 90 90 90 88 88 
                99 99 ND  99 99 99 99 99 99 98 
ATCC14019                   97 99 96 100 99 99 99 90 92 
                  99  ND 99 100 100 100 99 98 98 
N165                     97 97 97 96 96 96 91 93 
                     ND 99 99 99 99 99 98 98 
N164                       96 99 98 99 98 91 92 
                       ND ND ND ND ND ND ND 
41V                         96 96 96 96 91 92 
                        99 99 99 99 98 98 
ATCC14018T                           99 99 99 90 92 
                          100 100 99 98 98 
315-A                             99 99 90 92 
                            100 99 98 98 
HMP9231                               99 91 92 
                              99 98 98 
ATCC49145                                 90 92 
                                98 98 
N160                                   98 





Biotyping, sialidase, ARDRA genotyping and biofilm production 
Results for the biotyping assays and genotyping are shown in Table 2.4. Piot 
biotypes 1, 2, 5, 7 and 8 were identified among the isolate collection, but no consistent 
pattern of biotype distribution and cpn60 subgroup was observed. All subgroup C isolates 
were lipase positive. Subgroup B and C isolates were sialidase positive and ARDRA 
genotype 1, whereas subgroup A isolates were sialidase negative and genotype 2. 
Subgroup D isolates differed in sialidase (N160 was negative, strain 101 positive) and 
ARDRA genotype (N160 was genotype 2, strain 101 was predicted to be genotype 1 
based on in silico restriction analysis). All isolates produced biofilm in BHIG by 48 hrs, 
and substantial variability in biofilm production was observed in the two media tested 
(BHIG and ATCC broth #1685 with 1% glucose) (Figure 2.2). Both subgroup B isolates 
(N144 and N153) formed biofilm in both media, although the biofilm formed in BHIG 
was more extensive, completely coating the well. In subgroups A and C, at least one of 
the isolates failed to produce any visible biofilm in ATCC broth #1685.  
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Table 2.4. Piot biotype, sialidase and ARDRA characterization of G. vaginalis isolates 
(representatives of study isolates with unique cpn60 sequences) and published whole genome 
sequences.  
 
1L = Lipase, B = β-galactosidase, H = Hippurate hydrolase, ND = not done. 
2Study isolates N156 (subgroup B) and N164 (subgroup C) were not included in the biotyping analysis 
since they were not reliably cultured as pure isolates. 
3In cases where no isolates were available to us for culture, ARDRA genotypes for some strains (41V, 
ATCC 14019, 101, AMD, 409-05, and 5-1) were obtained by in silico analysis as described in the text. 
  
cpn60 subgroup Isolate2 Piot Biotype1 Sialidase ARDRA3 
L B H Biotype 
C 
41V ND ND ND ND + 1 
N165 + + - 8 + 1 
ATCC 14018 + + + 1 + 1 
ATCC 49145 + + - 8 + 1 
ATCC 14019 ND ND ND ND + 1 
B 
N144 - - + 5 + 1 
N153 - - + 5 + 1 
D 
101 ND ND ND ND + 1 
N160 - - + 5 - 2 
A 
AMD ND ND ND ND - 2 
N137 - - - 7 - 2 
N134 - - + 5 - 2 
409-05 ND ND ND ND - 2 
5-1 ND ND ND ND - 2 
N158 + - + 2 - 2 
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Figure 2.2. Biofilm formation by G. vaginalis.  
Isolates were cultured in 96-well plate in two different media: ATCC broth #1685 and BHI, stained at 48 
hrs, after removal of planktonic cells. 
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We also attempted to detect vaginolysin gene sequences in the isolates selected 
for phenotypic analysis. A PCR product of the expected size of 1,551 bp was obtained for 
only three isolates (ATCC 14018T, ATCC 49145 and N153).  An amplicon of 1,200 bp 
was amplified from three others (N134, N137 and N158), but sequence analysis indicated 
a mixture of products, suggesting that this product was the result of non-target sequence 
amplification. Isolates N165 and N144 did not yield any product after repeated attempts. 
The vaginolysin sequence from ATCC 49145 was identical to ATCC 14018 and only 
89% identical to N153. 
Distribution of G. vaginalis subgroups in Kenyan women 
A previously published cpn60 metagenomic dataset was used to investigate 
distribution of cpn60-based G. vaginalis subgroups in vaginal microbiome profiles 
derived from samples classified as BV, Intermediate or Normal based on Nugent score 
(Schellenberg et al. 2011a). All unique sequences assembled from the study data (n=831 
OTU) were compared using watered-BLAST (Schellenberg et al. 2009a) to a reference 
database of cpn60 sequences containing one representative of each species in cpnDB 
(cpnDB_nr; www.cpndb.ca) and two representatives of each G. vaginalis subgroup as 
indicated in Figure 1. All assembled sequences with any of the G. vaginalis reference 
sequences as their best match, and meeting the minimum requirement for identification as 
a cpn60 sequence (60% identity over ≥100 nucleotides) were included in the analysis of 
distribution (n=93). For 84/93 of the assembled metagenomic sequences, the top two hits 
were to the same G. vaginalis subgroup. Identities for each query and its top two hits 
(medians for 93 queries were 96.6% and 92.9% respectively) were significantly (p < 
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0.0001) higher than identity to the third (median 89.4%) through eighth best hits (Figure 




Figure 2.3. Percent identity of metagenomic sequences to G. vaginalis reference strains.  
Distribution of percent identity of G. vaginalis metagenomic sequences to their first through eighth best 
matches (x axis values 1 to 8) among representative sequences of the G. vaginalis subgroups. The reference 
database included two representatives of each subgroup, indicated in Figure 1. Significant differences in 
percent identity (p<0.0001) are indicated by *. 
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Once metagenomic sequences were assigned to a subgroup (based on the best 
watered-BLAST match) the distribution of the subgroups among the vaginal 
microbiomes of women diagnosed as BV (n = 20), Intermediate (n = 5) and Normal (n = 
19), based on Nugent score was determined (Figure 2.4). The sequence read frequencies 
used in this analysis were normalized to the median library size of 15,000 reads 
(Schellenberg et al. 2011a). All vaginal microbiota libraries contained sequences 
corresponding to more than one subgroup of G. vaginalis. Out of 44 libraries sequenced, 
41, 43, 43 and 27 contained G. vaginalis subgroup A, B, C and D respectively. The 
majority of libraries (25/44) contained sequence from all four subgroups. The next most 
prevalent combination was A+B+C (n=14 libraries), while other combinations were 
present in the remaining four samples (n=1 for A+C, n=2 for B+C, n=1 for B+C+D, n=1 
for A+B+D). The difference in frequencies of G. vaginalis subgroup sequence reads was 
tested using Kruskal-Wallis H test (SPSS Statistics, version 17.0). A significant 
difference (χ2 value = 12.329, df = 2, p = 0.002) was observed only for subgroup B 
sequences. Pairwise comparison on subgroup B sequences between the clinical groups 
(BV, Intermediate, and Normal) was analyzed by Mann-Whitney U test and results 
showed a significantly greater abundance of subgroup B sequences in BV compared to 




Figure 2.4. Distribution of G. vaginalis subgroups in African women.  
Relative abundance of sequence reads corresponding to Gardnerella subgroups (scaled to median library 
size of 15,000 reads) among clinical categories (BV, Intermediate and Normal, based on Nugent score). 
Boxplots were created for each Gardnerella subtype and p values calculated based on non-parametric 
significance tests (Mann-Whitney U test) using SPSS Statistics version 19.0.  
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2.5 Discussion 
Bacterial vaginosis is the most commonly reported vaginal infection (Fethers et 
al. 2008; Ness et al. 2004). BV can be diagnosed clinically using Amsel’s criteria, which 
include presence of homogenous vaginal discharge, a vaginal pH of greater than 4.5, 
positive whiff test (production of a fishy odour on addition of 10% KOH to vaginal 
sample), and also presence of clue cells in at least 20% of the total cell count (Amsel et 
al. 1983). The Nugent score is another commonly used diagnostic tool for BV. To 
calculate the Nugent score, a Gram stained vaginal smear is assessed for the relative 
abundance of various bacterial morphotypes including Gram-positive large rods, Gram-
negative/Gram-variable rods and curved Gram-variable rods. With increasing numbers of 
survey studies in which Nugent scores of clinically normal women are determined, the 
phenomenon of “asymptomatic BV” has been widely observed (Gibbs 2007; Leitich and 
Kiss 2007; Mastrobattista et al. 2000). These women have high Nugent scores, but do not 
have symptoms of BV. The clinical significance of asymptomatic BV is unknown. Since 
the presence of G. vaginalis is one of the key determinants of Nugent score, one possible 
explanation for asymptomatic BV is the presence of large numbers of non-pathogenic G. 
vaginalis or other species with similar Gram stain morphology. If this is true, then the 
detection of G. vaginalis in general may be of questionable diagnostic value. Resolution 
of this important issue requires the investigation of distribution of G. vaginalis lineages 
among women in a variety of clinical cohorts. Tackling this on a large scale requires 
culture-independent tools that provide resolution of phenotypically distinct G. vaginalis 
subgroups when applied directly to clinical samples. 
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Sequence diversity within G. vaginalis has been reported in metagenomic studies 
of the vaginal microbiome based on 16S rRNA and cpn60 gene targets, and four 
subdivisions have been reported in several recent studies (Hill et al. 2005a; Hummelen et 
al. 2010; Schellenberg et al. 2011b). The subdivision observed by Hummelen et al. 
(2010) was based on single nucleotide differences within the V6 region of 16S rRNA. 
The much lower cpn60 sequence identity between these subgroups (≤93% versus ≥98% 
identity for 16S rRNA) facilitated the identification of vaginal isolates corresponding to 
these subgroups, demonstrating that the metagenomic studies had revealed real biological 
diversity and not artifactual diversity resulting from PCR, sequencing and or data 
assembly (Figure 2.1). Overestimation of microbial diversity in metagenomic sequencing 
studies is an ongoing concern (Reeder and Knight 2009). So the identification and 
characterization of actual isolates corresponding to metagenomic sequences is reassuring 
and further supports the value of the cpn60 universal target for resolution of diversity at 
species- and strain-level (Vermette et al. 2010).  
Whole genome DNA–DNA hybridization persists as the gold standard method for 
defining bacterial species (1988) although it remains unpopular due to its technical 
demands (Cho and Tiedje 2001). DNA sequence data is increasingly relied upon to 
support species definition and resolution, and recently whole genome sequence 
comparison has been suggested as a new gold standard (Richter and Rossello-Mora 
2009). Richter & Rosselló-Mora (2009) demonstrated that average nucleotide identity 
(ANI) values correlate well with DNA-DNA hybridization results and suggest that an 
ANI values greater than ≈95-96%, calculated by either BLAST or the MUMmer rapid 
aligning tool, were indicative of bacteria of the same species. Another alternative was 
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proposed by Ziegler, who developed a computational algorithm based on sequence of 
three genes (recN, rpoA and thdF) that corresponds well to the conclusions of DNA-DNA 
hybridization data (Zeigler 2003). In that study, the 16S rRNA gene, widely used for 
identifying bacterial species and metagenomic studies, was found to have the lowest 
correlation between sequence identity and genome sequence identity. Subsequently, 
Verbeke et al. (2011) demonstrated that a cpn60 UT sequence alone could predict whole 
genome identity as well as the three-gene model. The ease of amplifying and sequencing 
the cpn60 UT from bacteria, the curated reference database of chaperonin sequences 
(cpnDB, www.cpndb.ca) (Hill et al. 2004), and the ability of the cpn60 UT to predict 
whole genome sequence similarity make it the ideal target for studies of Gardnerella, or 
any other bacterial taxon for which subspecies resolution is of interest.  
Our results show a strong relationship between cpn60 UT sequence identity and 
whole genome comparison with the ANIm algorithm in JSpecies (Table 2.2). In fact, our 
results suggest that subgroups A, C and D of G. vaginalis meet the whole genome 
sequence-based criteria for designation as different species. Although no whole genome 
sequence is available for a subgroup B isolate, the cpn60 sequence data for isolates in this 
group certainly support a similar species level status for this group (Table 2.3). Complete 
genomes of nine G. vaginalis strains were determined at the time of writing, and the fact 
that none of them belongs to subgroup B is interesting. Our experience with culturing of 
subgroup B isolates suggest that their conspicuous absence from the genome sequence 
database is most likely due to the fact that members of this subgroup, unlike the others, 
only grow in anaerobic conditions and do not grow in 7% CO2, which is the atmosphere 
recommended for routine isolation of G. vaginalis (Holt 1994).  
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The heterogeneity of the G. vaginalis taxon is well documented based on 
application of biotyping schemes. Some of the biotypes of G. vaginalis from both the Piot 
and Benito biotyping schemes have been associated with BV (Aroutcheva et al. 2001; 
Numanovic et al. 2008). Piot biotypes 1, 4 and 5 are the most frequently isolated 
regardless of BV status (Tosun et al. 2007) and biotype 5 has been reported to be 
predominantly associated with healthy vaginal ecosystems (Aroutcheva et al. 2001). Piot 
biotypes 7 and 8 have been reported as the most frequently isolated from BV patients 
with isolation rate of 32% and 20%, respectively (Aroutcheva et al. 2001). Of the seven 
isolates characterized in this study, four were Piot biotype 5, supporting previous 
observations of the prevalence of this biotype (Table 2.4). Otherwise, biotyping results 
were not consistent with sialidase, ARDRA or observations of association with BV in the 
Kenyan cohort. Sialidase activity is recognized as a virulence factor in G. vaginalis and is 
the basis for a chromogenic, BV Blue Kit for BV diagnosis (Kampan et al. 2011). 
Furthermore, although we did not provide evidence of sialidase enzymatic activity in our 
isolates, sialidase gene presence has previously been correlated with the ability of an 
isolate to produce active sialidase enzyme (Santiago et al. 2011b). We observed a 
consistent relationship between sialidase production and ARDRA genotype in that all 
genotype 1 isolates were sialidase positive and all genotype 2 isolates were sialidase 
negative, in agreement with previous observations (Santiago et al. 2011b). 
Vaginolysin is a protein toxin belonging to the cholesterol-dependent cytolysin 
family of toxins that has been previously identified in G. vaginalis (Gelber et al. 2008). 
To detect this purported virulence factor in the study isolates, we employed previously 
published PCR primers designed based on the type strain, ATCC 14018. The primers 
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failed to amplify the target sequence from most study isolates, and among the isolates for 
which we did generate sequence (ATCC 14018, ATCC 49145 and N153), we observed 
only 89% nucleotide sequence identity between some isolates (N153 vs. either the type 
strain or ATCC 49145). These results suggest that these primers may be too specific for 
general application in G. vaginalis, rather than indicating the absence of a vaginolysin 
gene in the other strains included in the study. 
Subgroups of G. vaginalis were not evenly distributed among vaginal 
microbiomes diagnosed as BV, intermediate or normal based on Nugent score (Figure 
2.4). Although G. vaginalis sequences were ubiquitous in the study group, and most 
women hosted multiple subgroups of G. vaginalis, only sialidase positive subgroup B 
was significantly more abundant in BV than normal samples. Analysis of pH and clue 
cells in these samples showed, as expected, a negative correlation of pH and Nugent 
score and a positive correlation of clue cells and Nugent score (data not show). An 
obvious and immediate question is whether subgroup B or any other subgroup is 
differentially associated with symptomatic and asymptomatic BV. Although we were 
unable to stratify our current data by symptoms (discharge, odour), relatively low cpn60 
sequence identities facilitate robust differentiation of G. vaginalis subgroups (Figure 2.1 
and 2.3) making it an ideal target to exploit in culture-independent approaches to 
addressing these questions in future studies. High throughput sequencing of cpn60 
amplicons (Schellenberg et al. 2009a), bead-based hybridization assays (Dumonceaux et 
al. 2009) and quantitative real-time PCR methods (Chaban et al. 2009) have all been 
developed based on cpn60 UT sequences and offer powerful tools for investigation of 
microbial diversity at, and below, the species level. 
 52 
The results of our work support previous observations of genotypic and 
phenotypic diversity within G. vaginalis and we have been successful in using cpn60 UT 
sequences for robust classification of available G. vaginalis strains into four subgroups. 
We have also provided evidence that supports the eventual reclassification of subgroups 
as different species of Gardnerella. The degree of cpn60 UT and whole genome sequence 
diversity within this taxon is beyond that associated with “ecotypes” (Cohan 2002) or 
strains and suggests that reclassification may be warranted. However, additional 
genotypic and phenotypic analysis of additional isolates will be required to make this 
case. The cpn60 UT sequence offers a robust tool for identification of subgroups within 
G. vaginalis that may not be discernable using other targets. This feature of the cpn60 
target will facilitate future efforts to expand diagnostic panels for rapid, high throughput 
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Third Chapter Transition 
In the previous chapter, four subgroups of G. vaginalis based on cpn60 UT were 
defined. During the same time another group (Ahmed et al. 2012) reported that G. 
vaginalis can be subdivided into four clades based on the whole genome sequences of 17 
isolates within this genus. In this chapter, I have reconciled cpn60 subgroups of G. 
vaginalis with the Ahmed et al. clades (Ahmed et al. 2012). The other objective I 
accomplished in this chapter is to resolve the four subgroups based on their proteome 
profiles. These results indicated that subgroups are recognizable using more than one 
method of resolving bacterial species. The next important information required about 
these subgroups is the identification of phenotypic and molecular factors that might 
indicate their clinical significance. Hence, sialidase enzymatic activity of subgroups and 
also their antimicrobial susceptibility to metronidazole and clindamycin were 
investigated. The final objective of this chapter was to identify any subgroup specific 
protein biomarker candidates with diagnostic potential.  
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3.1 Abstract 
Gardnerella vaginalis is a ubiquitous member of the vaginal microbiome that 
plays an ambiguous role in the pathogenesis of bacterial vaginosis (BV). Although 
phenotypic and phylogenetic diversity in this organism is well known, recent work has 
confirmed four genotypically distinct subgroups (A-D), which are unevenly distributed 
among women with BV as determined by Nugent score. To further characterize the 
subgroups, we assessed several phenotypic and molecular factors of G. vaginalis 
subgroups, using representative isolates of each subgroup grown to stationary phase. 
Presence and activity of sialidase was determined through gene-specific PCR and the 
filter-spot enzymatic assay, antimicrobial resistance patterns for metronidazole and 
clindamycin were determined using E-strips, and whole-cell proteomic profiles were 
generated by SDS-PAGE. Sialidase gene sequences were detected in all subgroups, 
however enzymatic activity was detected only in subgroup B. Proteomic profiles of 
isolates within each subgroup formed unambiguous clusters, with subgroup B isolates 
expressing apparently large amounts of a 43.7 kDa protein identified using mass 
spectrometry as a putative ABC transporter substrate binding protein (COG2182: 
maltose-binding periplasmic proteins/domains). A clear definition of G. vaginalis 
subgroups in terms of molecular and phenotypic traits, as well as their distribution in the 
context of the vaginal microbiome, will be critical to a better understanding of the 
pathogenesis of BV. Characterization of specific protein markers for each subgroup is 
likely to lead to the development of novel diagnostic methods for this common but poorly 
understood clinical entity.  
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3.2 Introduction 
The most common vaginal condition affecting reproductive aged women is 
bacterial vaginosis (BV), characterized by a shift in the composition of the vaginal 
microbiota from a Lactobacillus dominated community to a polymicrobial community, 
dominated by anaerobes (Spiegel 1991). G. vaginalis is a hallmark organism of BV, 
however it is also detected routinely in clinically healthy women (Harwich et al. 2010). 
The phenotypic heterogeneity of G. vaginalis is well known, and several biotyping and 
genotyping schemes have been developed to describe this diversity (Benito et al. 1986; 
Piot et al. 1984; Santiago et al. 2011b; Tosun et al. 2007). More recently, it has been 
demonstrated that this taxon consists of four genotypically and phenotypically distinct 
subgroups that may constitute separate species. These subgroups can be discriminated on 
the basis of concatenated sequences of 332 genes common to G. vaginalis isolates 
(Ahmed et al. 2012), or by sequencing a single 552 bp region of cpn60, also known as the 
“universal target” or UT (Paramel Jayaprakash et al. 2012). It has not yet been 
determined if these genotypic subgrouping schemes are consistent with each other or if 
clinically significant phenotypic characteristics are differentially distributed among 
subgroups. There is only limited information on the association between any particular 
subgroup or clade of G. vaginalis and BV status, including the results of our own 
previous work (Paramel Jayaprakash et al. 2012). Recently, quantitative PCR using 
subgroup-specific probes has shown associations between G. vaginalis subgroups and 
Nugent score in 60 women attending a vaginitis clinic in the United States (Balashov et 
al. 2014). 
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Sialidase activity is an important virulence factor associated with BV, aerobic 
vaginitis, and adverse pregnancy outcomes (Cauci and Culhane 2011; Marconi et al. 
2013; Zhang et al. 2002). Although this activity is widely detected in G. vaginalis, the 
trait is not common to all isolates, and expression levels are variable among sialidase 
positive isolates (Lewis et al. 2013). Some recent studies have investigated the presence 
of sialidase genes in relation to sialidase activity and molecular subgroups (Pleckaityte et 
al. 2012a; Santiago et al. 2011b). Our previous work has demonstrated that sialidase 
genes could be detected in cpn60 defined subgroups B and C, however enzymatic activity 
was not determined (Paramel Jayaprakash et al. 2012). We are unaware of any previous 
studies that have addressed antibiotic resistance or whole-cell protein profiles of G. 
vaginalis subgroups.  
The objectives of the current study were to reconcile current genomic and 
phenotypic descriptions of G. vaginalis subgroups defined by cpn60 and whole genome 
sequences, and to expand on the phenotypic descriptions of G. vaginalis subgroups with 
the goal of identifying characteristics that can be exploited in further investigations of 
their clinical significance, and their detection and identification. Our results demonstrate 
that clades defined by Ahmed et al. (2012), based on supragenome genome analyses of 
17 G. vaginalis genomes, correspond to cpn60 subgroups, and furthermore that cpn60 
subgroups are distinguishable based on whole cell protein profiles. The detection of 
sialidase enzymatic activity in only one of the cpn60-defined subgroups and the 
identification of subgroup-specific proteins that likely play a role in nutrient uptake 
support the hypothesis that G. vaginalis subgroups are also ecologically distinct, having 
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different relationships with the host and the other constituents of the vaginal microbial 
community.  
3.3 Materials and methods 
Bacterial cultures 
All G. vaginalis isolates included in this study are listed in Table 3.1. G. vaginalis 
isolates ATCC 49145 and ATCC 14018T were obtained from the American Type Culture 
Collection. All other isolates were from vaginal samples of Kenyan and Canadian 
women, as previously described (Schellenberg et al. 2012). The current study focuses on 
a set of 13 isolates, including 9 that have been previously characterized (Paramel 
Jayaprakash et al. 2012). These isolates represent four cpn60 defined subgroups of G. 
vaginalis: subgroup A (isolates N137, N134, N158), subgroup B (N144, N170, N95, 
W11, N101, N153), subgroup C (N165, ATCC 14018T, ATCC 49145) and subgroup D 
(N160). A new set of 35 isolates, identified to the subgroup level by cpn60 UT 
sequencing as described previously by Hill et al. (Hill et al. 2006a) was also examined 
for confirmatory tests. Freezer stocks in skim milk-glucose or ATCC broth #1685 (NYC 
III medium) with 10% glycerol (v/v) were revived on Columbia blood agar or Mueller-
Hinton blood agar (MHB), both with 5% sheep blood (BD, Mississauga, ON) and 
incubated anaerobically at 37°C using the GasPak EZ Pouch System (BD, Mississauga, 
ON). Isolated colonies were sub-cultured in ATCC broth #1685 and incubated as above. 
Stationary phase was determined by measuring absorbance of the culture at 600 nm and 




Table 3.1: G. vaginalis isolates included in the study. NA represents ‘Not available’. 
cpn60 
subgroup 
Ahmed et al. 
clade Isolate 
Isolate 
available cpnDB ID 
Whole genome accession 
number (Bioproject) 
A 4 N134 Yes b15982 NA 
  N137 Yes b15981 NA 
  N143 Yes b26701 NA 
  N148 Yes b26702 NA 
  N158 Yes b26703 NA 
  N72 Yes b15953 NA 
  409-05 No b15920 PRJNA31001 
  AMD No b16964 PRJNA40893 
  5_1 No b17423 PRJNA40895 
  B476 No b21788 PRJNA42441 
B 2 N101 Yes b26700 PRJNA265097 
  N144 Yes b15978 NA 
  N156 Yes b15975 NA 
  N170 Yes b26704 NA 
  N95 Yes b26706 PRJNA265092 
  W11 Yes b26707 PRJNA265103 
  JCP7659 No NA PRJNA181314 
  JCP7719 No NA PRJNA181316 
  JCP8017A No NA PRJNA181317 
  JCP8017B No NA PRJNA181318 
  JCP8066 No NA PRJNA181319 
  JCP8070 No NA PRJNA181320 
  JCP8151A No NA PRJNA181322 
  JCP8151B No NA PRJNA181323 
  JCP8522 No NA PRJNA181326 
  N153 Yes b15977 PRJNA265102 
  B513 No b21784 PRJNA42449 
  B482 No b21783 PRJNA42451 
C 1      ATCC 49145 Yes b26699 NA 
  N164 Yes b15970 NA 
  N165 Yes b15969 NA 
  JCP7275 No NA PRJNA181312 
  JCP7276 No NA PRJNA181313 
  JCP7672 No NA PRJNA181315 
  JCP8108 No NA PRJNA181321 
  41V No b18714 PRJNA200477 
  ATCC 14019 No b13658 PRJNA31473 
  B472 No b21791 PRJNA42431 
  B473 No b21790 PRJNA42437 
  B474 No b21789 PRJNA42437 
  B477 No b21787 PRJNA42443 
  B478 No b21786 PRJNA42445 
  ATCC 14018T Yes b291 PRJNA46675 
  HMP9321 No b19071 PRJNA51067 
  315-A No b19054 PRJNA52049 
D 3 N160 Yes b15973 NA 
  B479 No b21785 PRJNA42447 
  B483 No b21782 PRJNA42453 
  B512 No b21781 PRJNA42455 
  101 No b18713 PRJNA53359 
OUTLIER OUTLIER JCP8481A No NA PRJNA181324 
OUTLIER OUTLIER JCP8481B No NA PRJNA181325 
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Phylogenetic analysis and whole genome sequence comparisons 
Phylogenetic analysis was performed by aligning sequences using ClustalW (gap 
opening penalty = 10, gap extension penalty = 0.10) (Thompson et al. 1994). Bootstrap 
values were determined using 100 iterations of the alignment, and distance matrices 
calculated using the F84 algorithm of dnadist in the PHYLIP software package 
(Felsenstein 1996). Phylogenetic trees were constructed using neighbor and consense in 
the PHYLIP package, and visualized using Dendroscope (Huson et al. 2007). For whole 
genome sequence comparisons, pairwise Average Nucleotide Identity (ANI) values 
between whole genome sequences were calculated using the MUMmer algorithm 
(ANIm) within the JSpecies software package for intergenome similarity comparisons 
(Richter and Rossello-Mora 2009). 
Sialidase detection, Piot biotyping and antimicrobial susceptibility testing 
PCR for the detection of the sialidase gene was performed using primers GVSI 
forward and GVSI reverse as previously described (Santiago et al. 2011b). A modified 
filter paper spot test was used for detecting sialidase enzyme activity of G. vaginalis 
isolates (Moncla and Braham 1989) with the fluorogenic substrate 2'-(4-
methylumbelliferyl)-α–D-N-acetylneuraminic acid sodium salt hydrate (Sigma-Aldrich 
Canada, Oakville, ON). Substrate was dissolved in water to a concentration of 0.015% 
w/v (1 mg in 6.6 mL) and 180 µL aliquots stored at -20°C. Prior to the assay, thawed 
aliquots were diluted with 20 µL 1M sodium acetate (pH 5.8) and 10 µL added to filter 
spots. Isolates were sub-cultured on Columbia blood agar as described above and 
harvested with a sterile swab into 2 mL autoclaved saline (0.85% NaCl, pH 7.4) until 
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turbidity was equivalent to 5 McFarland. Sialidase activity was determined by visualizing 
filter spots under UV light after addition of 20 µL diluted culture and incubation for 15 
min in the dark at 37°C. Based on preliminary experiments, ATCC 14018T and isolate 
W11 were used as negative and positive controls respectively. To ensure that enzymatic 
activity was responsible for the positive reaction, the assay was repeated with diluted 
cultures that had been boiled for 30 min (enzyme-negative control). Biotyping was 
carried out on selected isolates using the Piot scheme (Piot et al. 1984), including assays 
for hippurate hydrolysis, β-galactosidase and lipase activity as previously described (Piot 
et al. 1984). Susceptibility testing for clindamycin and metronidazole was performed 
using E-test strips (bioMérieux, St. Laurent, Canada) as recommended by the 
manufacturer, with cultures diluted to 0.5 McFarland units and spread for confluent 
growth on MHB plates at 37°C for 48 hrs. 
Protein preparation and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) 
Protein extracts for 13 representative isolates were obtained from three replicate 
cultures. Bacterial cells were harvested from stationary phase cultures by centrifugation 
at 3900 × g for 5 min, washed three times with PBS and re-suspended in SDS lysis 
buffer, containing Tris (0.5 M, pH 6.8), SDS (8.8% w/v), glycerol (35.6% v/v), and 
bromophenol blue (0.3% w/v). Cell suspensions were sonicated (6 pulses of 30 sec, with 
each round followed by 2 min of cooling on ice) and cell debris was removed by 
centrifugation at 20,000 × g for 30 min at 4°C. Supernatants containing extracted proteins 
were stored at -80°C until analysis. Total protein concentration was determined using the 
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DC Protein Assay Kit II (Bio-Rad, Mississauga, ON). Protein extracts (75 µg total 
protein per isolate) were resolved on a 12% SDS-PAGE gel containing three lanes of size 
markers (Precision Plus Protein Standards, Bio-Rad, Mississauga, ON), stained with 
Coomassie brilliant blue overnight and destained for 20 min. Gels were scanned and 
images saved as .tiff files for analysis of band patterns using gel comparison software 
(GelCompar II V6.1, Applied Maths Inc. Austin, TX). Dendrograms were generated 
using UPGMA clustering with the Dice co-efficient, and 0.6% optimization and 0.8% 
position tolerance values. For more precise estimation of protein sizes and band 
intensities, selected extracts were resolved on an Agilent Bioanalyzer 2100 using the 
Protein 80 chip according to the manufacturer's instructions. 
Protein identification by mass spectrometry 
Bands corresponding to proteins apparently differentially expressed among G. 
vaginalis subgroups were excised. Mass spectrometry was performed for peptide mass 
determination using a Quadrupole Time-Of-Flight (Q-TOF) Global Ultima mass 
spectrometer (Micromass, Manchester, UK) at the National Research Council of Canada, 
Saskatoon, SK. RAW mass spectra data files obtained for each sample were processed 
with ProteinLynx Global Server 2.4 (PLGS 2.4, Waters) to generate PKL files containing 
peptide mass/charge ratio and intensity values. Each PKL data file was submitted to 
Mascot (Matrix Science Ltd., London, UK) for comparison of peptides to the SwissProt 
protein database, NCBI protein database and either to the predicted proteomes of G. 
vaginalis isolates N153 (cpn60 subgroup B, NCBI BioProject PRJNA265102) or B479 
(1500E)(cpn60 subgroup D, GCA_000263595.1). The predicted proteome for each 
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genome was generated using getorf within the EMBOSS package (Rice et al. 2000) to 
identify all predicted open reading frames of at least 100 nucleotides. 
3.4 Results 
Groupings of G. vaginalis by cpn60 universal target and whole genome sequences 
In order to reconcile the genome sequence-based grouping scheme described by 
Ahmed et al. (2012) with the cpn60 universal target based scheme described by 
Jayaprakash et al. (2012), phylogenetic analysis of cpn60 universal target sequences (552 
bp) extracted from whole genome sequences described in Ahmed et al. (2012), cpn60 
universal target sequences from Jayaprakash et al. (2012) and also from isolates 
described in a study by Lewis et al. (2013) was performed (Figure 3.1). Results of the 
analysis indicate that the four "clades" identified based on 332 concatenated genes are 
consistent with cpn60 subgroups, with cpn60 subgroup A corresponding to clade 4, 
subgroup B to clade 2, subgroup C to clade 1 and subgroup D to Clade 3 (Figure 3.1). 
Isolates JCP8481A and JCP8481B (Human Microbiome Project), which were not 
included in either previous study, shared a node (99% bootstrap support) with subgroup 
A, although they were only 89 - 91% identical to other subgroup A isolates. Pairwise 
comparisons of cpn60 UT sequences of G. vaginalis isolates within and between 
subgroups results in a bimodal distribution of inter- and intra-subgroup similarity values 
(Figure 3.2A). The only overlap between distributions occurs at 94% identity, a value 
representing 7 pairwise comparisons (6 intra-group and 1 inter-group). Pairwise Average 
Nucleotide Identity values calculated using the MUMmer algorithm exhibited a similar, 
bimodal distribution (Figure 3.2B). Within each subgroup, ANIm values were ≥ 95%, 
while between subgroup values ranged between 88% and 91% identity.  
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Figure 3.1.  Phylogenetic analysis of the cpn60 UT sequences of Gardnerella vaginalis. 
Phylogenetic tree of nucleotide sequences (alignment length = 552 bp) of cpn60 sequences from G. 
vaginalis (n=53) from four subgroups (A – D). The tree is rooted with Alloscardovia omnicolens. 
Sequences from isolates with names starting with B were obtained from Ahmed et al. (2012). All other 































































































Figure 3.2. Pairwise comparisons of cpn60 UT sequences and whole genome ANIm values of G. 
vaginalis isolates.  
A: Distribution of cpn60 UT sequences pairwise percent identity values for 52 G. vaginalis isolates. B: 
























































Piot biotyping, sialidase activity and antimicrobial sensitivity 
Piot biotyping results for four new study isolates and nine previously described 
isolates representing the four cpn60-defined subgroups are summarized in Table 1. β-
galactosidase activity was detected only in subgroup C, and these isolates were 
determined to be Piot biotype 1 or 8. All subgroup B isolates were Piot biotype 5, but 



















1 Piot biotype and sialidase gene detection by PCR of all isolates except N170, N95, W11 and N101 were 
previously described in Jayaprakash et al. (2012) and are included here for context. 
2L = Lipase, B = β-galactosidase, H = Hippurate hydrolase. Biotype designation is according to Piot 
biotyping scheme (Piot et al. 1984).  










A N137 7 - > 256 0.04 
 N134 5 - > 256 < 0.01 
 N158 2 - > 256 0.04 
B N144 5 + > 256 0.08 
 N170 5 + > 256 0.05 
 N95 5 + > 256 0.05 
 W11 5 + 16 0.10 
 N101 5 + > 256 0.04 
 N153 5 + > 256 0.04 
C N165 8 - > 256 no growth 
 ATCC 14018T 1 - 3 0.02 
 ATCC 49145 8 - 0.38 0.01 
D N160 5 - > 256 0.02 
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MIC values for metronidazole were ≥ 256 µg/mL for all isolates except for W11, 
ATCC 14018T and ATCC 49145. Based on National Committee for Clinical Laboratory 
Standards (NCCLS) guidelines, MIC values for W11, ATCC 14018T and ATCC 49145 
were below the breakpoint of resistance of ≥32 µg/mL for metronidazole. All isolates 
were sensitive to clindamycin with MIC values ≤ 0.1 µg/mL, below the NCCLS 
breakpoint of ≥8 µg/ml (Table 3.1). No trend was observed in the relationship between 
cpn60 subgroup affiliation and susceptibility to metronidazole or clindamycin. 
All 13 isolates, phenotyped by Piot biotyping (Piot et al. 1984) were also tested 
for sialidase activity using a modified filter spot assay. Interestingly, only subgroup B 
isolates were positive for sialidase activity in the filter spot assay (Table 3.1). Based on 
these results, ATCC 14018T (subgroup C) was selected as negative control and W11 
(subgroup B) was selected as positive control in the subsequent experiment. Using a set 
of previously published primers for detecting the sialidase gene (Santiago et al. 2011b), 
an expanded subgroup of 35 isolates was tested for presence of the sialidase gene. In the 
expanded group of 35 isolates, all but one of nine new subgroup B isolates was PCR 
positive, and only one of three new subgroup D isolates was PCR positive. All nine new 
subgroup C isolates were PCR positive, and only very weak bands were observed for 
eight of 14 new subgroup A isolates (data not shown). Again, only subgroup B isolates 
were positive for sialidase activity in the filter spot assay in the expanded set of isolates 
(Figure 3.3). These findings suggest that enzymatic activity is largely inconsistent with 




Figure 3.3. Sialidase filter spot test results for G. vaginalis isolates. 
G. vaginalis isolates (n=35) representing cpn60 subgroups A-D were tested using sialidase filter spot 





To investigate the relationship of whole cell protein profiles of G. vaginalis 
isolates representing the four subgroups, SDS-PAGE banding patterns of protein extracts 
from triplicate cultures of 13 isolates were compared. Protein profiles of isolates in each 
subgroup clustered together, forming distinct clades according to cpn60 subgroup (Figure 
3.4). Minimum percent similarity values within each subgroup ranged from 58% to 79%. 
Comparison of SDS-PAGE banding patterns identified an ~40 kDa protein apparently 
highly expressed by all six subgroup B isolates (Figure 3.5) and an ~45 kDa protein 
apparently highly expressed by the subgroup D isolate. For a more precise estimate of 
protein size, extracts of subgroup B isolate N153 and subgroup D isolate N160 were 
analyzed using the Bioanalyzer Protein 80 chip. The protein bands of interest were found 
to correspond to apparent protein sizes of 43.7 kDa and 49 kDa respectively 
(Supplementary Figure 3.1). Protein bands of interest were excised from the SDS-PAGE 
gels of N153 and N160 for peptide mass spectrometry. For N153, duplicate samples of 
















































































































































































































































































































































Figure 3.4. Dendograms of whole cell protein profiles of G. vaginalis isolates. 
Dendograms were created from whole cell protein profiles using UPGMA clustering of Dice co-efficient 
values with 0.6% optimization and 0.8% position tolerance values. cpn60 subgroup and isolate name, 
followed by replicate number, are indicated. Protein size marker lanes (Ladder) and sterile media extracts 




   
Figure 3.5. Protein profiles of G. vaginalis isolates.  
Protein extracts (75 µg) from isolates of G. vaginalis from four cpn60 subgroups (indicated below gel) and 
sterile broth (Media) were run on SDS PAGE (12%) along with 15 µg of ladder. Bands excised for peptide 










































































































Supplementary Figure 3.1. Bioanalyzer profiles of protein extracts from G. vaginalis isolates 
A: Bioanalyzer profile for protein extract from G. vaginalis N153 showing peak at 43.7 kDa (arrow). B: 






 In both replicate experiments with N153, peptide mass patterns matched a 
predicted ORF in the N153 genome (Gene ID in JGI: 2528387946, encoding 409 aa,) that 
was annotated as an ABC transporter substrate-binding protein belonging to COG2182 
(maltose-binding periplasmic proteins/domains). Since the whole genome sequence of 
subgroup D isolate N160 was not available, peptides from N160 were compared to the 
predicted proteome of G. vaginalis B479 (1500E) (NZ_ADES00000000.1), which was 
identified as belonging to subgroup D based on cpn60 UT sequence analysis (Figure 3.1). 
The protein excised from extracts of N160 corresponded to an ORF in G. vaginalis B479 
(1500E) (EIK82014.1, encoding 448 aa), which was annotated as an ABC sugar transport 
system periplasmic component belonging to COG1653 (ABC-type sugar transport 
system, periplasmic component). 
The primary sequence of proteins identified in subgroup B and subgroup D 
isolates were searched for conserved domains using a NCBI conserved domain search 
against the conserved domain database (CDD). Two domains were identified within the 
protein identified from the subgroup B isolate N153 genome: periplasmic binding 
component of ABC transport system specific for an unknown oligosaccharide 
(periplasmic binding fold, PBP2_oligosaccharide_1) and a malE type maltose-binding 
periplasmic domain. Four conserved domains were identified the predicted protein from 
subgroup D isolate G. vaginalis B479 (1500E): a bacterial extracellular solute-binding 
protein domain (SBP_bac_8); type 2 periplasmic binding fold superfamily 
(Periplasmic_Binding_Protein_Type_2 super family); ABC-type sugar transport system, 
periplasmic component (UgpB), and magnesium chelatase domain, H subunit (BchH).  
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To investigate the presence of orthologous sequences in other G. vaginalis 
isolates corresponding to the proteins of interest, genomes of G. vaginalis from 
representatives of subgroups A, B, C and D (35 total genomes) were searched using 
BLASTp with the proteins of interest as queries. Sequences of predicted protein 
orthologs and their corresponding nucleotide sequences were extracted from the 
annotated genomes. Orthologous nucleotide sequences from Bifidobacterium species 
were identified using the IMG/ER database (Joint Genome Institute, 
https://img.jgi.doe.gov/cgi-bin/er/main.cgi) and included in the subsequent phylogenetic 
analysis. Phylogenetic trees showing the relationships of genes predicted to encode 
subgroup- specific proteins and their nearest neighbours in other subgroups are shown in 






Figure 3.6.  Phylogenetic tree of nucleotide sequences predicted to be ABC transporter substrate-
binding protein (subgroup B) from G. vaginalis and Bifidobacterium spp. 
Phylogenetic tree of nucleotide sequences  (1295 bp alignment) of best matches from G. vaginalis genomes 
(n=35) from four subgroups (A – D) and from genomes of Bifidobacterium spp. to an ORF encoding a 

































































Figure 3.7. Phylogenetic tree of nucleotide sequences predicted to be ABC transporter substrate-
binding protein (subgroup D) from G. vaginalis and Bifidobacterium spp. 
Phylogenetic tree of nucleotide sequences (1389 bp alignment) of best matches from G. vaginalis genomes 
(n=36) from four subgroups (A – D) and from Bifidobacterium species to an ORF encoding a predicted 


































































An ortholog of the predicted maltose-binding protein encoding gene identified in 
N153 was identified in all subgroup B genomes, with nucleotide sequence identities 
>98% to N153 (Figure 3.6). Sequences with 94-95% nucleotide sequence identity were 
identified in subgroup C genomes, but these sequences formed a distinct clade in the tree 
with good bootstrap support. The subgroup B and C orthologs were also distinguishable 
at the protein sequence level (data not shown). Nucleotide sequence identities between 
subgroup B and related sequences from subgroups A and D were much lower (<78% 
nucleotide sequence identity), and similar to those observed between Bifidobacterium 
species. These findings indicate that different protein profiles of the G. vaginalis 
subgroups may result from the expression of a gene that is either present (in subgroup B) 
or absent (subgroups A, C and D), rather than differential expression of a conserved gene.  
A similar clustering pattern was observed for the putative ABC transporter 
substrate-binding protein identified in subgroup D (Figure 3.7). A closely related 
sequence (94% identity) with a common node with good bootstrap support was identified 
in the only other subgroup D isolate (101) for which a whole genome sequence is 
available. These subgroup D specific sequences were clearly distinct from the nearest 
sequences in the other subgroups (85-89% identical to orthologous sequences in 
subgroups A, B and C).  
3.5 Discussion 
Previous investigations of the relationship of G. vaginalis biotypes or genotypes 
and women’s clinical characteristics have been limited by dependence on diagnostic 
features that require culture of isolates. Methods such as biotyping (Benito et al. 1986; 
Piot et al. 1984) and ARDRA (Santiago et al. 2011b) require culture isolation before they 
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can be applied. The association of any single G. vaginalis isolate with a complex clinical 
entity such as BV is problematic since G. vaginalis can readily be isolated from clinically 
healthy women as well as those with BV (Aroutcheva et al. 2001; Verhelst et al. 2004), 
and individual women can be colonized by a diverse mixture of G. vaginalis strains 
simultaneously (Aroutcheva et al. 2001; Chaban et al. 2014; Paramel Jayaprakash et al. 
2012). In other words, the observation that a particular isolate is from a woman diagnosed 
with BV is not sufficient evidence to infer causation or designate that isolate as 
"pathogenic". Understanding the role of diverse G. vaginalis strains in vaginal microbial 
ecology and determining any systematic association with BV and other health outcomes 
depends upon the further elucidation of characteristics that differentiate G. vaginalis 
strains, as well as the development of methods to detect biologically relevant groups in 
the context of the entire microbiome.  
 Our phylogenetic analysis confirms that four recently described “clades” (Ahmed 
et al. 2012) are the same as the four cpn60-defined subgroups defined in our previous 
work (Paramel Jayaprakash et al. 2012) (Figure 1). Furthermore, the bimodal distribution 
of pairwise ANIm values is consistent with the suggested bacterial species level cut-off 
of 95-96% proposed by Richter et al. (2009), with all inter-subgroup identities ≤91% and 
all intra-subgroup identities ≥95% (Figure 3.2). The consistency between these reported 
genotyping schemes was not unexpected given previous demonstrations of the prediction 
of whole genome similarity based on cpn60 universal target sequences (Verbeke et al. 
2011). Although the genotypic requirements for designation of the four G. vaginalis 
subgroups as separate species have arguably been met (Richter and Rossello-Mora 2009), 
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identification of additional phenotypic properties that consistently resolve these 
subgroups is required before a formal proposal of reclassification can be made.  
Antimicrobial resistance patterns were not helpful in subgroup resolution. 
According to the National Committee for Clinical Laboratory Standards (NCCLS) 
guidelines, the breakpoints of resistance are ≥32 µg/mL for metronidazole and ≥8 µg/mL 
for clindamycin. In the current study, all isolates other than the ATCC strains were 
resistant to metronidazole, but all isolates tested were also sensitive to clindamycin. 
These results are consistent with previous reports (Goldstein et al. 2002; Shanker et al. 
1982; Tomusiak et al. 2011). Metronidazole and clindamycin are the two main drugs 
used by clinicians for the treatment of BV (Greaves et al. 1988; Powell 2013) and are 
administered either orally or compounded in gels or creams. There are however 
numerous reports of resistance to metronidazole by G. vaginalis isolates (Aroutcheva et 
al. 2001; Goldstein et al. 2002; Kharsany et al. 1993; McLean and McGroarty 1996). 
Proposed mechanisms of metronidazole resistance in G. vaginalis include inactivation or 
deletion of genes encoding nitroreductase activity (Edwards 1993), biofilm formation 
(Swidsinski et al. 2008), and inhibition of penetration of the drug by a dense layer of 
fimbriae on the cell surface (McLean and McGroarty 1996).  
Although there was no clear pattern of Piot biotypes among the representative 
isolates, the detection of β-galactosidase activity was unique to subgroup C, and may 
represent a potential defining characteristic for this subgroup (Table 3.1). All isolates 
from subgroup B belong to Piot biotype 5 and are positive for sialidase enzyme activity 
(Table 3.1 and Figure 3.3), while isolates from other subgroups belonged to a number of 
different biotypes and were all-negative for sialidase activity. In a recent study where 
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sialidase activity was determined quantitatively (Lewis et al. 2013), a wide range of 
activity levels was reported among isolates. Our analysis of cpn60 sequences from 
isolates included in this previous study (Figure 1) shows that all but one sialidase positive 
strain belong to cpn60 subgroup B (isolates with names beginning with JCP in Figure 
3.1). The one remaining sialidase positive isolate (JCP7276) belongs to subgroup C. 
Although all isolates of subgroup C included in the current study were PCR positive for 
sialidase gene, none had detectable sialidase enzyme activity. Taken together, these 
findings may indicate that some subgroup C isolates have sialidase activity at levels 
below the detection limit of the filter spot assay used in this study. Differential sialidase 
production by G. vaginalis subgroups has potential clinical significance since sialidase 
activity of vaginal fluid is proposed as a marker for diagnosing BV (Briselden et al. 1992; 
Cauci et al. 2005; Shujatullah et al. 2010). Sialidase and other mucolytic enzymatic 
activities in vaginal fluid are likely detrimental to the protective mucous layer and have 
been proposed to play a role in recurrent BV (McGregor et al. 1994).  
Total protein profiling using PAGE is an important molecular technique used for 
bacterial systematics, and for species or strain level resolution (Hesselberg and Vreeland 
1995; Jackman 1982; Stanley et al. 1993). The four subgroups of G. vaginalis were 
resolved by protein profiles in this study. For subgroups B and D, we identified putative 
biomarker proteins, both of which are predicted to be components of ATP-binding 
cassette (ABC) transporters. Similar proteins are present in all bacteria, where they 
participate in transporting a variety of molecules, including nutrients, across the cellular 
membrane (Higgins 1992, 2001). ABC transporters include a substrate binding protein, 
two transmembrane proteins, and two membrane-associated nucleotide-binding proteins. 
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Based on their primary amino acid sequences, both subgroup B and D biomarker proteins 
were identified as having domain characteristics consistent with extracellular solute 
binding proteins, and more specifically, domains characteristic of maltose/maltodextrin-
binding proteins typified by MalE in E. coli (Ehrmann et al. 1998), and sn-glycerol-3-
phosphate (G3P) binding protein UgpB in E. coli (Overduin et al. 1988), respectively.  
Similarity between the Mal and Ugp ABC transporter systems has been noted (Hekstra 
and Tommassen 1993), and the identification of proteins that may be involved in uptake 
of maltose/maltodextrin in G. vaginalis is noteworthy given the significance of these 
nutrients in the vaginal ecosystem. Glycogen, expressed by vaginal epithelium, promotes 
the colonization of Lactobacillus. However, most vaginal isolates of Lactobacillus cannot 
degrade glycogen and utilize it directly (Stewart-Tull 1964; Wylie and Henderson 1969). 
Instead, Lactobacillus utilizes the breakdown products of glycogen including maltose, 
maltotriose, maltopentaose, and maltodextrin, which are products of human α-amylase 
activity on glycogen (Spear et al. 2014). Efficient uptake of glycogen breakdown 
products by some G. vaginalis strains, facilitated by high levels of expression of ABC 
transporter components, would lead to direct competition with Lactobacillus, which 
could have significant consequences for vaginal microbial community composition and 
dynamics. Although fermentation of maltose is a diagnostic characteristic of G. vaginalis 
(Greenwood and Pickett 1979), the mechanisms for its uptake or the uptake of related 
maltodextrin compounds are not known. Further in vitro characterization of the putative 
biomarker proteins identified in this study to elucidate substrate specificity and 
expression patterns is ongoing. 
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In summary, our results demonstrate that “clades” based on supragenome genome 
analyses of 17 G. vaginalis genomes, correspond to cpn60 subgroups, and furthermore 
that cpn60 subgroups are distinguishable based on whole cell protein profiles. The 
detection of sialidase enzymatic activity in only one of the cpn60-defined subgroups and 
the identification of subgroup-specific proteins that likely play a role in nutrient uptake 
support the hypothesis that G. vaginalis subgroups are also ecologically distinct, having 
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Fourth Chapter Transition 
This chapter follows observations made during investigation of objectives 
accomplished in previous chapters, one of which was the observation of the potential 
clinical significance for subgroup B G. vaginalis. Subgroup B G. vaginalis was found to 
be significantly more abundant in a cohort of Kenyan women grouped into ‘BV’ category 
than ‘Normal’ based on the Nugent score. Subgroup B was the only group with sialidase 
enzymatic activity among the four subgroups of G. vaginalis. It was also observed that 
two isolates belonging to subgroup B were obligate anaerobes that did not grow in 7% 
CO2 atmosphere.  
Due to the significant relationship illustrated throughout the literature between 
anaerobes and BV, anaerobic isolates of G. vaginalis were of substantial interest. Hence, 
this chapter focuses on addressing how genomes of anaerobic isolates of subgroup B 
differ from facultative isolates of subgroup B G. vaginalis.  
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4.1 Abstract 
Four distinct subgroups of the vaginal bacterium Gardnerella vaginalis have been 
defined based on cpn60 universal target sequences. Sialidase enzymatic activity is 
confined to subgroup B and this subgroup has previously been observed to be 
significantly more abundant in the vaginal microbiomes of African women with BV than 
those with healthy vaginal microbiota. In the current study, the growth characteristics of 
subgroup B isolates in an anaerobic atmosphere and in a 7% CO2 atmosphere were 
investigated. While all isolates grew anaerobically, some isolates were incapable of 
growth in 7% CO2. To determine genome content differences that could account for this 
phenotypic difference, the whole genome sequence of four G. vaginalis subgroup B 
isolates representing facultative and anaerobic phenotypes were determined. A 15 kb 
contiguous fragment present in the facultative isolates W11 and N95, as well as in 703C2 
and ATCC 14109 (publically available genome sequences, reported to grow in 7% CO2), 
was absent in anaerobic isolates N153 and N101. The fragment contains genes predicted 
to encode an epimerase, reductase and ABC transporter that might be involved in 
protecting the cells from oxidative damage and allowing the cells to grow in the presence 
of oxygen. Similarly, a 21 kb contiguous fragment was present only in the obligate 
anaerobic strains, which based on predicted functionality of COG categories for ORFs in 
the fragment, are speculated to be involved in cell wall biogenesis. Given the well-known 
relationship between an anaerobic microbiota and BV, anaerobic isolates of G. vaginalis 
are potentially important players in the vaginal microbial community.  
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4.2 Introduction 
The clinical significance of G. vaginalis was described even before its current 
name was proposed. It was initially associated with the condition of non-specific 
vaginitis in cases where other agents of vaginitis such as Trichomonas and Candida were 
not detected (Catlin 1992). Diversity within G. vaginalis is well recognized, and recently 
genomic and phenotypic evidence has been provided to demonstrate that G. vaginalis 
comprises at least four different subgroups that likely represent different species. 
Differential distribution of the subgroups among women with varying clinical status 
(Balashov et al. 2014; Paramel Jayaprakash et al. 2012) suggests that G. vaginalis should 
not be considered as a single entity in the evaluation of vaginal health. 
Sialidase activity is considered an important virulence factor in BV and although 
a gene predicted to encode sialidase can be detected by PCR in both subgroup B and C, 
only subgroup B isolates have been shown to have sialidase enzyme activity using the 
filter spot test ((Paramel Jayaprakash et al. 2012) and Chapter 3). Another indication of 
the potential clinical significance of G. vaginalis subgroup B comes from the observation 
that this subgroup was significantly more abundant in samples from women with BV than 
those without BV in a study of 44 Kenyan women (Paramel Jayaprakash et al. 2012). Our 
interest in further characterization of the G. vaginalis subgroups led to growth 
experiments in which it was observed that all isolates from all subgroups grew on 
Columbia blood agar containing 5% sheep blood in a 7% CO2 atmosphere except for one 
isolate from subgroup B. The isolate from subgroup B N153 did not grow even after 84 
hrs. However, when isolates were incubated with anaerobic gaspaks, growth was 
observed for all isolates within 48 hrs.  
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G. vaginalis has been proposed to be an initial colonizer during the transition 
from a healthy vaginal microbiome to BV (Patterson et al. 2010; Schellenberg et al. 
2011b). Anaerobic G. vaginalis strains may play a role in establishing a BV environment, 
producing biofilm and acting as stage setters for the takeover of strict anaerobes, 
ultimately leading to the shift from lactobacilli to a mixed anaerobic microbial 
community that defines BV. The isolation of obligate anaerobic strains of G. vaginalis 
has been reported occasionally (Catlin 1992; Malone et al. 1975), but no further 
characterization of these isolates has been done and the genomic determinants 
responsible for this phenotypic property are unknown. 
The goals of the current study were to investigate growth of isolates of G. 
vaginalis subgroup B in anaerobic and aerobic environments. Based on the initial results 
of this investigation that illustrated differences in tolerance of oxygen, we compared the 
whole genome sequences of anaerobic and facultative subgroup B isolates to identify 
gene content differences that might explain the observed phenotypic differences.  
 
4.3 Materials and Methods 
Isolates and culture conditions 
G. vaginalis isolates were cultured on Columbia blood agar plates containing 5% 
sheep blood (BD, Mississauga, ON) or BBLTM V Agar (BD, Mississauga, ON), which is 
selective media for G. vaginalis containing 5% human blood. For resurrection of archived 
isolates, Columbia sheep blood agar plates were inoculated from -80 °C frozen stocks 
and incubated at 37 °C for 72 hrs under anaerobic conditions generated using the GasPak 
EZ Anaerobe Pouch System (BD, Mississauga, ON), which produces an atmosphere with 
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only residual oxygen (<0.1%) and ≥10% CO2 within 90 minutes. Isolates were 
subcultured once and their identities confirmed prior to the growth experiment by 
amplifying and sequencing the cpn60 universal target as previously described (Hill et al. 
2006a). Amplicon products were purified (EZ-10 spin column PCR product purification 
kit, Bio Basic Canada Inc., Markham, ON, Canada) and sequenced using Sanger 
sequencing. Raw sequence data were assembled using pregap4 and gap4 (Staden et al. 
2000) and compared to the cpnDB database (www.cpndb.ca) for identification.  
For growth comparisons in different atmospheres, streak-based culture plates 
were made using a loopful (1µl loop, Fisher Scientific, Catalog No.: 22-363-603, Whitby, 
ON, Canada) of culture for each isolate. Plates were incubated at 37 °C for 48 hrs under 
two sets of conditions: in a 7% CO2 incubator or anaerobic conditions as described 
above. Growth was scored on a scale of 0 to 4 where a score of 0 indicates no colonies, a 
score of 1 indicates colonies on the first streak and <10 colonies on the second streak, a 
score of 2 indicates ≥10 colonies on the second streak and <10 colonies on the third 
streak, a score of 3 indicates ≥10 colonies on the third streak and <10 colonies on the 
fourth streak and a score of 4 indicates ≥10 colonies on the fourth streak. Triplicate 
experiments were performed with two plates evaluated per isolate in each triplicate (six 
plates total per isolate). Results for each isolate were reported as an average of the six 
individual scores. 
Genomic DNA extraction and whole genome sequencing 
G. vaginalis isolates N153, N101, W11 and N95 were grown in ATCC broth 
#1685 anaerobically at 37 °C to stationary phase, and genomic DNA was extracted from 
cultures using a modified salting out procedure (Martín-Platero et al. 2007). Extracts 
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were stored at -80 °C in TE buffer (1 mM EDTA, 10 mM Tris HCl, pH 7.4). 
Identification of isolates was confirmed by amplification and sequencing of the cpn60 
universal target (UT) region (Hill et al. 2006a). The quality of genomic DNA extractions 
was assessed by spectrophotometric measurements (A260:A280 ratio of 1.8-2.0).  
Sample preparation and whole genome sequencing was done as described in the 
GS Junior whole genome shotgun sequencing protocol (Roche, Brandford, CT). 
Sequence assembly was done using gsAssembler (v2.7). 
Genome sequences were submitted to the Joint Genome Institute (JGI - 
https://img.jgi.doe.gov/cgi-bin/er/main.cgi) for annotation service. Publically available 
whole genome sequence for G. vaginalis B482 (00703C2mash, Genbank Accession 
NZ_ADEU00000000) was also used for the whole genome comparison as this strain has 
a cpn60 sequence identical to all four sequenced G. vaginalis isolates, and is described in 
the literature as being able to grow in 6% CO2 (Ahmed et al. 2012). 
COG categories were assigned to the open reading frames of individual genomes 
by JGI. Average Nucleotide Identity (ANI) between whole genome sequences was 
calculated using the MUMmer algorithm (ANIm) within JSpecies (Richter and Rossello-
Mora 2009). Pangenome analysis of G. vaginalis genomes was conducted using GView 
(Petkau et al. 2010) server for CDS (coding DNA sequence) with the following settings: 
genomes were compared against each other using tblastn with expect value cutoff of 
1×10-10; coding sequences (CDS) from genomes were translated into amino acid 
sequence using the genetic code of Bacteria; minimum alignment length cutoff value of 




Following the observation of a single isolate (N153) of subgroup B not being able 
to grow in 7% CO2 atmospheric conditions during a growth curve experiment, all 
available isolates of subgroup B (N153, N144, N170, N101, N95 and W11) along with 
the type strain ATCC 14018 (subgroup C) were tested for growth under four sets of 
conditions: 7% CO2 or anaerobic atmosphere on either Columbia sheep blood agar or 
human blood based media (V agar). All isolates formed colonies on Columbia sheep 
blood agar plates as well as V agar when incubated anaerobically at 37 °C for 48 hrs, 
with scores ranging from 2 to 3 (Table 4.1). All isolates except N153 and N101 formed 
colonies in 7% CO2 after 48 hrs. N153 and N101 did neither grow on Columbia sheep 
blood agar plates nor on V agar even after 72 hrs when incubated in 7% CO2 atmospheric 
conditions. For N170, growth was observed with average scores of 1.8 to 2.5 under all 
conditions, but the colonies formed on either medium in the 7% CO2 atmosphere were 
much smaller in comparison to colonies formed on plates incubated anaerobically (Table 
4.1 and Supplementary Figure 4.1).  
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Table 4.1. Growth of G. vaginalis subgroup B isolates and type strain on sheep blood agar and 
human blood agar (V agar) in anaerobic or 7% CO2 atmospheres. Scores shown are an average ± 
standard deviation of 6 replicate plates (3 biological replicates and 2 technical replicate for each 
biological replicate run). 
 
  Sheep blood agar V agar 
Isolate Subgroup Anaerobic 7% CO2 Anaerobic 7% CO2 
N144 B 2.50 ± 0.55 2.17 ± 0.98 2.50 ± 0.84 2.33 ± 0.52 
N153  2.17 ± 0.75 0.00 ± 0.00 2.33 ± 0.52 0.00 ± 0.00 
N170  2.50 ± 0.55 1.83* ± 0.75 2.17 ± 0.63 2.00* ± 0.89 
N101  2.17 ± 0.41 0.00 ± 0.00 2.50 ± 0.55 0.00 ± 0.00 
N95  2.67 ± 0.52 3.00 ± 0.00 3.00 ± 0.00 2.67 ± 0.52 
W11  2.50 ± 0.82 2.17 ± 0.41 2.00 ± 0.00 2.00 ± 0.00 
      








Supplementary Figure 4.1: G. vaginalis N170 on human blood based agar plate (V agar) and on 
Columbia blood agar plates containing sheep blood 
 A: N170 on human blood based agar plate (V agar) incubated at anaerobic conditions. B: N170 on 
Columbia blood agar plates containing sheep blood incubated at anaerobic conditions. C: N170 on human 
blood based agar plate (V agar) incubated at 7% CO2. D: N170 on Columbia blood agar plates containing 
sheep blood incubated at 7% CO2. 
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To determine genome content differences between obligate anaerobic and 
facultative isolates, N153, N101, W11 and N95 were chosen for whole genome analysis. 
These isolates were chosen since their cpn60 UT sequences are identical, and cpn60 UT 
sequence relationships have been shown to predict whole genome sequence relationships 
(Verbeke et al. 2011). Based on this, we predicted that genome sequences of anaerobic 
isolates N153 and N101 and facultative isolates W11 and N95 would all be very similar 
to each other, and that any gene content differences identified would be likely to be 
responsible for the anaerobic versus facultative phenotypes. Though N153 and N101 
were isolated from the same woman, they were chosen for whole genome sequence 
comparisons for two reasons. First, these two isolates were the only ones available that 
exhibited the strict anaerobic phenotype. The second reason was that it is known that 
women can be colonized by multiple strains of G. vaginalis (Schellenberg et al. 2012), 
and these two isolates might be different strains with gene content difference that can be 
ruled out as being responsible for the anaerobic phenotype.  
Whole genome shotgun sequencing of the four selected isolates was performed, 
resulting in 152,896 to 194,763 high quality filter passed reads per genome with an 
average read length of 463, and providing 39× to 59× coverage (Supplementary Table 
4.1). Reads from each isolate were assembled using the Newbler assembly algorithm of 
the Roche de novo assembler (v2.7), resulting in 7-10 large contigs (>500 bp) per 
genome and N50 values (defined as the size of the smallest contig in the list of contigs 
(with equal or larger size) that will amount to half of the assembled genome) of 485,233 
(N153), 689,064 (N101), 450,244 (W11) and 386,601 (N95). Since G. vaginalis B482 
has an identical cpn60 sequence to the four study isolates and is reported to grow in 6% 
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CO2 (Ahmed et al. 2012), the draft genome sequence of B482 (NZ_ADEU00000000) 
was included in the subsequent analysis. B482 is a clinical isolate from a woman with a 
Nugent score of 10 and was obtained from the Magee-Women's Research Institute, 
Pittsburgh, PA (Ahmed et al. 2012).  
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Supplementary Table 4.1: Comparison of genome sequencing run parameters of G. vaginalis 
genomes N153, N101, N95 and W11. 
 
 Benchmark N153 N101 N95 W11 
Raw wells ≤250,000 197,876 239, 283 245,687 255,250 
Keypass wells >90% 191,816 233,283 239,100 248,817 
High Quality reads 50,000-80,000 152,896 194,763 162,783 162,913 
% Filter passed >50% 79.71 83.39 68.08 63.8 
% Mixed+Dots <20% 3.3 2.73 4.13 4.2 
% Too Short Quality <30% 16.7 16.54 23.36 28.93 





GenBank format genome sequences of N153, N101, W11, N95 and B482 were 
submitted to the Joint Genome Institute (https://img.jgi.doe.gov/cgi-bin/er/main.cgi) and 
were annotated using the JGI Integrated Microbial Genomes Expert Review (IMG/ER) 
service. A description of genome features for G. vaginalis isolates N153, N101, W11, 
N95 and B482 is given in Table 4.2. All four sequenced Gardnerella genomes (N153, 
N101, W11 and N95) and B482 were ~1.5 Mb in size with 42% G+C content. All five 
genomes have 45 tRNA genes and one copy of the 16S rRNA gene, indicating that if 
there are multiple copies of  the16S rRNA operon, they are either very similar or identical 
to the assembled one. Gene, COG, Pfam and KEGG count for these four genomes were 
1234-1261, 959-973, 1009-1038 and 401-409 respectively. There was no obvious pattern 
in variation of the parameters described in Table 4.2 that suggested the phenotype 
difference observed for the facultative versus anaerobic phenotype. 
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N101 1543396 1234 10 42 1 45 959 1018 407 
N95 1522480 1235 7 42 1 45 967 1009 409 
B482 1546682 1253 22 42 1 45 971 1038 408 
W11 1566657 1258 7 42 1 45 973 1028 407 
N153 1541878 1261 7 42 1 45 965 1025 401 
1COGs - Clusters of Orthologous Groups of proteins database contains proteins from completely sequenced 
genomes classified on the basis of the orthology concept. Orthologs are proteins that are direct evolutionary 
counterparts related by vertical descent between organisms. 
2Pfam - The Pfam database contains collection of protein families, each family represented by multiple 
sequence alignments and hidden Markov models (HMMs) containing proteins with similar functional 
regions, also called as domain, indicating similar functions. 
3KEGG (Kyoto Encyclopedia of Genes and Genomes) database integrates genomic, chemical and systemic 
functional information by obtaining gene catalogs from completely sequenced genomes and linking it to 




In order to gain further insight into overall similarities between genomes, pairwise 
ANIm (Average Nucleotide Identity by mummer algorithm) values of isolates of N153, 
N101, W11, N95 and B482 were calculated using JSpecies (Table 4.3). ANIm for N153 
and N101 was 99%, which was not unexpected since these two anaerobic isolates 
originated from the same woman. N153 and N101 were 96% similar to N95, W11 and 
B482. N95, W11 and B482 were also 96% similar to each other. Gene content 
differences are suggested by the ANIm values, however further in depth analysis was 




Table 4.3: Pairwise whole genome similarities of G. vaginalis subgroup B isolates based on ANIm 
(Average Nucleotide Identity by Mummer). 
 
 N153 B482 N101 N95 
W11 96.29 96.48 96.30 96.41 
N153  96.80 99.93 96.79 
B482   96.80 96.80 





To investigate the similarities at the level of their predicted proteomes for these 
isolates, COG profiles of N153, N101, N95, W11 and B482 were used to generate a 
histogram at the functional COG category level (Figure 4.1). Figure 4.1 shows the 
number of predicted genes assigned to each COG category. COG profiles were very 
similar among the five subgroup B isolates, with nearly identical distributions observed 




Figure 4.1: Histogram representing genes (number) assigned to COG categories for the facultative 
and anaerobic genomes.  
COG categories are represented using alphabets. E - Amino acid transport and metabolism, G - 
Carbohydrate transport and metabolism, D - Cell cycle control, cell division, chromosome partitioning, N - 
Cell motility, M - Cell wall/membrane/envelope biogenesis, B - Chromatin structure and dynamics, H - 
Coenzyme transport and metabolism, Z - Cytoskeleton, V - Defense mechanisms, C - Energy production 
and conversion, W - Extracellular structures, S - Function unknown, R - General function prediction only, P 
- Inorganic ion transport and metabolism, U - Intracellular trafficking, secretion, and vesicular transport , I - 
Lipid transport and metabolism, Y - Nuclear structure, F - Nucleotide transport and metabolism, O - Post-
translational modification, protein turnover, and chaperones, L - Replication, recombination and repair, A - 
RNA processing and modification, Q - Secondary metabolites biosynthesis, transport, and catabolism, T - 
Signal transduction mechanisms, K – Transcription and J - Translation, ribosomal structure and biogenesis. 



































N101 N153 B482 N95 W11 
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For a more detailed comparison of isolates and identification of strain-specific 
ORFs (Open Reading Frames specific to either facultative strains or to anaerobic strains), 
GView (https://server.gview.ca/) was used to display and navigate bacterial genomes. In 
order to identify ORFs unique to facultative genomes, the genome of a facultative strain 
(B482) was used as a seed genome. ORFs of other genomes are compared using tblastn to 
ORFs of the seed genome and ORFs with percent identity less than 70% over an 
alignment length of 100 are considered to be unique. The pangenome is then created by 
iterative addition of unique regions to the initial seed genome such that the resulting 
pangenome contains ORFs from all genomes. Regions not present in one genome are 
visible as gaps in the BLAST results for that genome against the pangenome.  
From the pangenome analysis, a contiguous 15 kb genome fragment was 
identified in B482, which was also present in W11 and N95, but was absent in the 
anaerobic strains N153 and N101. Figure 4.2 illustrates the 15 kb fragment, which 
contains 13 predicted ORFs that were only present in the facultative strains (N95, W11 
and B482). The COG functional categorization of these ORFs indicates that five out of 
thirteen ORFs are involved with cell wall/membrane/envelope biogenesis. Out of the 
remaining eight, three are predicted to be involved with carbohydrate metabolism and 
transport and one ORF is predicted to be a gene involved with lipid transport and 
metabolism. The COG categories for the remaining ORFs could either not be assigned 
(category Un) or were predicted for general functionality (category R). This fragment 
includes a predicted epimerase coding gene, described in the literature to be involved in 
capsule synthesis (Zuppardo and Siebeling 1998) and also a polysaccharide ABC 
transporter membrane protein coding gene, which is suggested to be involved in 
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transporting O-antigen and other sugar moieties such as rhamnose-glucose 
polysaccharide (synthesized by rhamnan synthesis protein F) to the exterior of the cell, 
enabling the formation of a capsule like structure. The annotations of these ORFs and 
their COG affiliations, suggest that this 15 kb fragment is involved in cell wall 




Figure 4.2: A 15 kb fragment present only in facultative strains (N95, W11 and B482) described 
using COG categories.  
  
COG category not defined 
M - Cell wall/membrane/envelope biogenesis 
I - Lipid transport and metabolism 
G - Carbohydrate transport and metabolism 
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Predicted genes from the above mentioned 15 kb fragment and other ORFs that 
were identified only in the facultative strains, and absent in the anaerobic strains, are 
listed in Table 4.4. Out of the 21 ORFs listed in the table, 13 ORFs (00041 to 00053 of 
N95) are located on the 15 kb fragment described above. The remaining 8 ORFs are 
scattered around the genome. Out of these eight, four (00019, 01005, 00486 and 00480 of 
N95) could not be assigned to a COG category, and one ORF (00484 in N95) was 
assigned to COG category R (General function prediction only). As with most of these 
genes in the unique list, one of the remaining three (00483, COG category M) is 
predicted to be involved in cell wall/membrane/envelope biogenesis. The remaining two 
(01023 and 00018 of N95) are interesting candidates to be considered, as they are 
predicted to be involved in replication, recombination and repair functions. Replication, 
recombination and repair related genes are important for any cell in protecting the cell 
against oxidative stress (Henry et al. 2012).  
 Table 4.4. ORFs present in facultative strains of G. vaginalis (B482, N95 and Wll) and absent in anaerobic strain (N153 and N101).  
COG category COG  JGI Annotation ORF # in 
B482 
ORF # in N95 
(% identity to 
ORF in B482) 
ORF # in 
W11 (% 
identity to 
ORF in B482) 
R General function 
prediction only 
COG3668 Plasmid stabilization system 
protein 
Addiction module toxin, RelE/StbE 
family protein  04281 00484 (100) 00965 (100) 
 COG1216 Predicted 






transport system, ATPase component  
ABC-type polysaccharide/polyol 
phosphate transport system, 
ATPase component 





biosynthesis protein  
Lipopolysaccharide biosynthesis 
protein 03156 00050 (91.5) 00757 (93.8) 
 COG1215 Glycosyltransferases, 
probably involved in cell wall 
biogenesis  
Glycosyltransferases 04286 00483 (99.6) 00964 (99.6) 
 COG1209 dTDP-glucose 








03196 00042 (97.5) 00765 (93.8) 
 COG1088 dTDP-D-glucose 4,6-
dehydratase  
dTDP-glucose 4,6-dehydratase (EC 
4.2.1.46) 03191 00043 (100) 00764 (95.4) 
 COG0463 Glycosyltransferases 
involved in cell wall biogenesis  
Glycosyltransferases involved in 
cell wall biogenesis 
03141 00053 (82.6) 00754 (84.0) 
  Glycosyltransferases involved in 
cell wall biogenesis 
03161 00050 (91.5) 00757 (93.8) 
  Glycosyltransferases involved in 
cell wall biogenesis 
03171 00047 (96.6) 00760 (100) 
L Replication, 
recombination and repair 
COG1195 Recombinational DNA 
repair ATPase (RecF pathway)  AAA domain 01429 01023 (99.8) 01135 (95.2) 
 COG1112 Superfamily, DNA and 
RNA helicases and helicase subunits  
type III restriction protein res 
subunit 03915 00018 (99.9) 00790 (100) 
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 I Lipid transport and 
metabolism COG1835 Predicted acyltransferases  Predicted acyltransferases 03151 00051 (96.9) 00756 (92.9) 
G Carbohydrate 
transport and 





export systems, permease component  
O-antigen export system permease 
protein 03181 00045 (100) 00762 (95.8) 
 COG0451 Nucleoside-diphosphate-
sugar epimerases  
Nucleoside-diphosphate-sugar 
epimerases 03176 00046 (96.8) 00761 (99.3) 
- -  KilA domain protein 03905 00019 (88.0) 00789 (96.9) 
- - Hypothetical protein 01499 01005 (100) 01161 (100) 
- - Hypothetical protein 04266 00486 (99.0) 00967 (99.0) 
- - Hypothetical protein 04296 00480 (99.3) 00962 (99.3) 
- - Glucosyltransferase GtrII 03166 00048 (98.0) 00759 (98.0) 
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Genes uniquely present in anaerobic strains, absent in the facultative strains are 
listed in Table 4.5. Sixteen of these ORFs are contained within a contiguous genome 
fragment of 21 kb size: ORFs numbered 00039 to 00055 in N153, 00658 to 00672 in 
N101, with 00660 in N101 corresponding to a fusion of 00041 and 00042 of N153 
(Figure 4.3). Five of these ORFs were assigned to COG category M (Cell wall 
biogenesis). ORFs corresponding to 00047 and 00048 in N153 are predicted to be 
involved in carbohydrate transport and metabolism (COG category G). ORF 00054 is 
predicted to be involved in replication, recombination and repair. Another ORF in this 
fragment (00046 in N153) is predicted to be involved in lipid transport and metabolism. 
The remaining ORFs in this fragment were assigned to COG category R (General 
functional predication only) or were unassigned. 
 
  
Table 4.5. ORFs present in anaerobic strains of G. vaginalis (N153 and N101) and absent in facultative strains (N95, W11 and B482) 
COG category COG  Description ORF # in N153 ORF # in N101 (% identity 
to  ORFs in N153) 
V Defense mechanisms COG1715 Restriction endonuclease Restriction endonuclease 
01110 00481 (100) 
R General function prediction only COG1216 Predicted glycosyltransferases Predicted glycosyltransferases 
00050 00668 (100) 
 COG3153 Predicted acetyltransferase Predicted acetyltransferase 
01104 00487 (100) 
 COG3668 Plasmid stabilization system protein 
Plasmid stabilization system 
protein 
00287 00896 (100) 
M Cell wall/membrane/envelope 
biogenesis COG0438 Glycosyltransferase Glycosyltransferase 
00049 00667 (100) 
   00040 00659 (100) 
 COG1088 dTDP-D-glucose 4,6-dehydratase 
dTDP-glucose 4,6-dehydratase 
(EC 4.2.1.46) 
00055 00672 (100) 
 COG3475 LPS biosynthesis protein LPS biosynthesis protein 
00044 00662 (100) 
 
COG4750 CTP:phosphocholine 
cytidylyltransferase involved in 
choline phosphorylation for cell 
surface LPS epitopes 
CTP:phosphocholine 
cytidylyltransferase involved in 
choline phosphorylation for cell 
surface LPS epitopes 
00041 00660 (98.4) 
L Replication, recombination and 
repair   
COG0494 NTP 
pyrophosphohydrolases 
including oxidative damage 
repair enzymes 
NTP pyrophosphohydrolases 
including oxidative damage 
repair enzymes 
00054 00671 (100) 
 COG3077 DNA-damage-inducible protein J 
addiction module antitoxin, 
RelB/DinJ family 
00146 00759 (100) 
J Translation, ribosomal structure 
and biogenesis 
COG1670 Acetyltransferases, 
including N-acetylases of 
ribosomal proteins 
Acetyltransferases, including N-
acetylases of ribosomal proteins 
00497 01100 (100) 
I Lipid transport and metabolism COG1835 Predicted acyltransferases Predicted acyltransferases 
00046 00664 (100) 
G Carbohydrate transport and 




phosphate transport system, 
00048 00666 (100) 
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export systems, permease 
component 
ABC-type polysaccharide/polyol 
phosphate export systems, 
permease component 
00047 00665 (100) 





dehydrogenase (E3) component, 
and related enzymes 
Mercuric reductase 
00267 00877 (100) 
- - Hypothetical protein 01261 00412 (100) 
- - abi-like protein 00554 00408 (100) 
- - Addiction module toxin, RelE/StbE family 
00147 00760 (100) 
- - BNR repeat-like domain 00939 00029 (99.89) 
- - Ca protein B-type domain 00556 00406 (100) 
- - Domain of unknown function (DUF4417) 
00496 01099 (100) 
- - Hypothetical protein 00039 00658 (100) 
- - Hypothetical protein 00045 00663 (100) 
- - Hypothetical protein 00052 00670 (99.4) 
- - Hypothetical protein 00053 00670 (99.4) 
- - Hypothetical protein 00130 00744 (100) 
- - Hypothetical protein 00244 00855 (100) 
- - Hypothetical protein 00495 01098 (100) 
- - Hypothetical protein 01023 00566 (100) 
- - Hypothetical protein 01084 00507 (100) 
- - Hypothetical protein 01102 00489 (100) 
- - Hypothetical protein 01119 00473 (100) 
- - Multidrug resistance efflux transporter 
00043 00661 (100) 
- - Phosphotransferase enzyme family 
00042 00660 (100) 
- - Transposase and inactivated derivatives 








COG category not defined 
M - Cell wall/membrane/envelope biogenesis 
I - Lipid transport and metabolism 
G - Carbohydrate transport and metabolism 













00044 00045 00046 00047 00048 00049 00050 00051 00052
0067000662 00663 00664 00665 00666 00667 00668 00669 00671 00672






 The majority of the ORFs (14/20) listed in Table 4.5 that are not part of the 21 kb 
contiguous fragment were not assigned to any COG category. Two of the remaining ones 
were assigned to COG category R, and four belong to the following COG categories: 
defense mechanisms (V), replication, recombination and repair (L), translation, ribosomal 
structure and biogenesis (J) and energy production and conversion (C). 
4.5 Discussion 
 Isolation conditions for the diverse group of organisms designated as G. vaginalis 
vary according to researchers (Ahmed et al. 2012; Aroutcheva et al. 2001; Lewis et al. 
2013; Malone et al. 1975). The conditions recommended by the American Type Culture 
Collection (http://www.atcc.org/) for the type strain of this species, ATCC 14018, include 
incubation in 7% CO2 atmosphere, however in some recent studies researchers have used 
anaerobic conditions while trying to isolate this organism (Lewis et al. 2013; 
Schellenberg et al. 2012). Malone et al. in 1975 isolated obligate anaerobic strains of G. 
vaginalis (Malone et al. 1975). Following this observation, researchers tried to isolate 
more obligate anaerobic strains of G. vaginalis, but found that they were not common and 
were unsuccessful (Bailey et al. 1979). The biological relevance of this observation was 
never understood and no association between obligate anaerobic G. vaginalis and 
phenotyping schemes such as Piot or Benito biotyping has been described.  
In their supragenome analysis of 17 G. vaginalis isolates, Ahmed et al. (2012) did not 
report any G. vaginalis isolates being obligate anaerobes, and all isolates included in that 
study were cultured on human blood tween (HBT) bilayer agar in 6 % CO2. One of their 
isolates, B482, has a cpn60 UT sequence identical to N153 and N101, subgroup B 
isolates that were found in our study to be anaerobic. The genome sizes (1.55 - 1.57 Mb) 
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and GC content (42%) of the whole genomes of the facultative (N95 and W11) and 
anaerobic (N153 and N101) described in this study are similar to the subgroup B (Ahmed 
et al. clade 2) isolates described by Ahmed et al. in their study of 17 G. vaginalis 
genomes (Ahmed et al. 2012). COG categorization of open reading frames for the five 
genomes was very similar (Figure 4.1) further suggesting that any gene content 
differences detected between the facultative and anaerobic strains would be related to 
their different atmospheric requirements.  
A pangenome analysis revealed contiguous genome fragments containing open 
reading frames present uniquely either in facultative strains or anaerobic strains (Figure 
4.2 and Figure 4.3).  Both contiguous fragments, either unique to anaerobic strains or 
facultative strains, are speculated to be involved with cell wall biogenesis based on the 
annotation of ORFs present in these fragments. The genome fragment uniquely present in 
facultative strains contained genes involved in cell wall biogenesis, carbohydrate and 
lipid transport and metabolism. This contiguous fragment also contains a predicted 
epimerase gene and a polysaccharide ABC transporter membrane protein coding gene. 
Epimerases have been described as critical for capsule synthesis and absence of this 
function is associated with the disruption of capsule synthesis (Zuppardo and Siebeling 
1998). The polysaccharide ABC transporter membrane protein is annotated as having 
substrate specificity to O-antigen and other sugar moieties such as rhamnose-glucose 
polysaccharide. O-antigen, also known O-specific polysaccharide, is made of repeating 
oligosaccharide subunits and can a major constituent of the bacterial outer membrane 
(Marolda et al. 2004). Polysaccharide capsules, composed of repeating oligosaccharides, 
are found on surfaces of many Gram negative and Gram positive bacteria (Moxon and 
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Kroll 1990). Capsule producing bacteria are involved in reducing the host 
proinflammatory immune response and are less subject to phagocytosis by macrophages 
and dendritic cells than non-encapsulated bacteria (Henry et al. 2012).  
All organisms have some defense as well as repair mechanisms to protect their 
proteins, lipids, RNA and DNA from reactive oxygen species (ROS). The protective 
mechanisms used by organisms vary and are most critical to strict anaerobes. One of the 
mechanisms described and studied scarcely in the literature is the cell wall and the role of 
different surface structures such as capsules in protecting the prokaryotes against 
oxidative stress (Henry et al. 2012). In Porphyromonas gingivalis (Henry et al. 2012) and 
also in the eukaryote Cryptococcus neoformans (yeast) (Zaragoza et al. 2008; Zaragoza 
et al. 2009), the presence of a capsule also protects the organism against oxidative stress. 
In Cryptococcus neoformans, the capsule acts as a scavenger of reactive oxidative species 
enhancing its survival when ingested by phagocytic cells (Zaragoza et al. 2008). The 15 
kb contiguous genome fragment only present in facultative strains is predicted to be 
involved in capsule synthesis. Since this fragment is absent in anaerobic strains, the 
capsule synthesized by this fragment might be involved in protective the facultative 
strains from oxidative stress and could be responsible for the phenotype of these strains 
being able to grow at 7% CO2 atmosphere.  
It is interesting to note that another contiguous genome fragment (21 kb fragment 
in figure 4.3) only present in anaerobic strains is also predicted to be involved with cell 
wall biogenesis. However, it does not include an epimerase gene and hence is not 
predicted to be involved in capsule synthesis. The absence of capsule in the obligate 
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anaerobic strains might be mitigated by the presence of a different cell wall design, 
allowing its survival in anaerobic conditions.  
The cell wall of G. vaginalis has always been described with caution, and the 
organism is referred to as "Gram variable" since it can appear as Gram positive or Gram 
negative based on growth stage or conditions (Catlin 1992). The cell wall of isolates of 
G. vaginalis including the type strain have been described as having a Gram positive 
organization, but with multiple laminations mimicking the Gram negative cell wall 
(Greenwood and Poickett 1980). An exopolysaccharide layer is thought to be involved in 
helping bacteria adhere to the epithelial cells (Catlin 1992). Harwich et al. observed a 
capsular structure on G. vaginalis isolate 5-1 that was not apparent for a closely related 
strain, AMD (both subgroup A strains). The authors speculated that the differential 
production of this polysaccharide capsular material might explain the differences 
observed in biofilm formation by these isolates (Harwich et al. 2010). The functionality 
of polysaccharide capsule in protecting the cells against oxidative stress remains 
unexplored in this group of organisms. 
Horizontal gene transfer via transposons, the CRISPR/Cas system, and phage-
mediated gene shuttling through mobile elements have all been reported in G. vaginalis 
(Pleckaityte et al. 2012b; Yeoman et al. 2010) and some combination of these processes 
is likely responsible for the differences in genome content we observed in this study. 
Further investigation into the functions of genes differentially detected in subgroup B 
isolates in the current study will help explain how they might be involved in protecting 
cells from oxidation damage, allowing W11, N95 and B482 to grow in concentrations of 
oxygen as high as 15-20% (found in CO2 incubators), much higher than the concentration 
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present in atmosphere generated by anaerobic Gaspaks (<0.1% oxygen). Clarifying the 
role of G. vaginalis in BV and the part it plays in tipping the balance in the vaginal 
microbial community from Lactobacillus dominance to a consortium of anaerobes 
depends upon resolution of phenotypically distinct subgroups within this diverse taxon 
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Fifth Chapter Transition 
The last three chapters have focused on improving the resolution of the vaginal 
microbiome specifically with respect to the genus Gardnerella. Through the 
accomplishment of objectives of categorizing Gardnerella into four subgroups using the 
cpn60 UT, and also establishing that there are clinical significances associated with these 
cpn60 subgroups, I have demonstrated cpn60 can be a very useful tool in providing a 
comprehensive and high resolution picture of any microbial community. 
 With that in mind, this chapter has focused on accomplishing the last objective. 
This chapter is prospective study of vaginal microbiota of women with PPROM using 
cpn60 based microbial profiling to identify any microbiome structure or pattern that can 
be used to predict maternal or neonatal outcomes.  
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5.1 Abstract  
Preterm premature rupture of membranes (PPROM) is a precursor to up to one 
third of all preterm births, and is associated with adverse maternal and neonatal 
outcomes. Delivery following PPROM can occur immediately or following an extended 
latency, and although abnormal vaginal microbiota has been implicated in triggering 
PPROM, the role of this microbial community in affecting latency duration is unknown. 
The objective of this study was to characterize the vaginal microbiota of women 
following PPROM, and to determine if microbiome composition predicts latency 
duration and perinatal outcomes. Microbiome profiles based on amplification and 
pyrosequencing of the cpn60 universal target were generated for vaginal swabs from 36 
women enrolled in the study, at the time of presentation with PPROM, once per week 
throughout the latency period, and at delivery. Microbiome profiles were generally 
dominated by one or two species including Lactobacillus crispatus, L. iners, Prevotella 
timonensis, P. bivia, G. vaginalis, and Escherichia coli. Only 13/70 samples examined 
were dominated by Lactobacillus spp., the expected profile for healthy women. 
Sequences representing Megasphaera type 1 and Prevotella spp. were detected in all 
vaginal samples collected throughout the study (n=70). Microbiome profiles at the time 
of membrane rupture did not cluster by gestational age at PPROM, latency duration, or 
chorioamnionitis diagnosis. The vaginal microbiota was generally unstable over the 
latency period, with dramatic shifts in composition between weekly samples, and an 
overall decrease in Lactobacillus abundance. Mollicutes (Mycoplasma and/or 
Ureaplasma) were detected by PCR in 81% (29/36) of women, and these women had 
significantly lower GA at delivery and correspondingly lower birth weight infants than 
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Mollicutes PCR negative women. The results of this study provide new insight into the 
vaginal microbiota of women who have experienced PPROM and demonstrate the 





Preterm premature rupture of the membranes (PPROM) is a precursor to 20-30% 
of all preterm deliveries (Goldenberg et al. 2008; Mercer 2003). The latency period 
between membrane rupture and delivery is a critical period for determining maternal and 
neonatal health outcomes, since while longer latencies have been associated with reduced 
odds of neonatal morbidity, (Frenette et al. 2013) there is an associated increase in risk of 
maternal or fetal infection (Simhan and Canavan 2005; Yudin et al. 2009). The interplay 
between gestational age (GA) at PPROM, latency, and maternal and neonatal morbidity 
results in a complex set of trade-offs for maternal and neonatal health, and presents 
profound challenges for management of PPROM during the watchful waiting period 
following membrane rupture.    
Abnormal vaginal microbiota is a recognized risk factor for PPROM (Epstein et 
al. 1998; Hillier et al. 1995; Leitich et al. 2003). The infectious etiology hypothesis 
suggests that in women with subclinical or clinical upper genital tract infections, bacteria 
ascend into the uterus causing an inflammatory response, which can lead to PPROM or 
preterm labour (Goldenberg et al. 2008; Locksmith and Duff 2001). Historically, 
anaerobes, Gram negative organisms and mycoplasmas have been associated with 
intrauterine infection (Goldenberg and Culhane 2003; Goldenberg et al. 2008; 
Goldenberg et al. 2005), and some specific microbial species have been associated with 
PPROM (Goldenberg et al. 1998). However, investigations have been limited by 
dependence on culture and isolation of fastidious organisms. 
Culture-independent methods based on high throughput DNA sequencing offer an 
unprecedented opportunity to investigate the microbiological aspects of PPROM. Studies 
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focusing on microbes in the fetal membranes, placenta and amniotic fluid of women with 
preterm birth, PPROM and term labour have resulted in the detection of a wider diversity 
of microbial species than culture dependent studies, as well as the identification of 
previously unrecognized species (DiGiulio et al. 2010; Fortner et al. 2014; Jones et al. 
2009; Wang et al. 2013), and results of these studies further support an association 
between bacterial colonization of fetal membranes and preterm birth. A recent study by 
Romero et al. (2014a) using 16S rRNA gene sequence-based techniques in a longitudinal 
study to compare vaginal microbial communities of pregnant women who subsequently 
delivered preterm or term identified no significant differences in microbiome 
composition or abundance of bacterial taxa between groups. However, differences in 
prevalence and abundance of organisms such as Leptotrichia/Sneathia, BVAB (BV 
associated bacteria), Mobiluncus spp. and Mycoplasma spp. in the vaginal microbiomes 
of women who deliver term or preterm have been reported in other recent studies 
employing culture-independent methods (Nelson et al. 2014; Wen et al. 2014).  
Information regarding the vaginal microbiota in PPROM is relatively scarce, and 
the composition and dynamics of the vaginal microbiota through the latency period 
following PPROM is currently unexplored using culture-independent methods. While 
there is certainly an urgent need for improved diagnostic tools for the prediction of risk of 
PPROM, there is an equal need for tools to aid in management of the latency period once 
PPROM has occurred. The objectives of the current study were to characterize the 
vaginal microbiota of women presenting with PPROM and throughout their latency, and 
to determine if vaginal microbial profile at the time of membrane rupture predicts latency 




This was a prospective study of women with PPROM between 24+0 and 33+6 
weeks gestational age. Patients were recruited at the BC Women's Hospital in Vancouver, 
Canada and were enrolled in the study if they met inclusion criteria: adequate 
comprehension of English language to give written informed consent, singleton gestation, 
no known fetal anomalies or complications distinct from PPROM, and no maternal or 
neonatal indication for iatrogenic PPROM. Ruptured membranes were confirmed by 
evidence of vaginal fluid pooling, fluid with an elevated pH demonstrated by a positive 
nitrazine test, and a positive ferning test.  
The study received ethics approval from the University of British Columbia 
Children’s & Women’s Research Ethics Board (certificate no. H08-01904).  
Three vaginal swabs were collected from each woman at enrolment: for 
Chlamydia and Gonorrhea testing, Gram stain assessment using Nugent Score, and for 
microbiome characterization. Additional samples were collected weekly until delivery, 
and at delivery (n=2 per sampling time, for Gram stain and microbiome analysis). 
Vaginal swabs were sent immediately to the BC Children’s Hospital and BC Women’s 
Hospital and Health Centre Laboratory for NAAT testing for C. trachomatis and N. 
gonorrhoeae (Cook et al. 2005; Van Dyck et al. 2001) and Nugent score assessment. 
Swabs for microbiome analysis were stored at -80 °C until processing.  
Demographic and clinical characteristics were collected from patient charts. 
Clinical chorioamnionitis was diagnosed based on maternal pyrexia of  >38°C and at 
least two of the following: fetal tachycardia >160 bpm, maternal tachycardia >120 bpm, 
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leukocyte count >14000 cells, uterine tenderness and/or foul amniotic fluid. 
Histopathological chorioamnionitis was diagnosed based on placental pathology (Queiros 
da Mota et al. 2013).  
Neonatal outcome data collected from the infant charts included; APGAR score 
(Pediatrics 2006), MAIN score (Verma et al. 1999), birth weight, gender, and admission 
to the Neonatal Intensive Care Unit (NICU). For neonatal skin microbiome sampling, 
swabs were taken from behind the earlobe and were processed and analyzed in the same 
manner as the vaginal swabs. 
Microbiome profiling 
Total genomic DNA was extracted from vaginal swabs using a magnetic bead-
based kit (MagMAX, Life Technologies, Burlington, ON). PCR amplicon libraries were 
created as described previously (Hill et al. 2006a; Schellenberg et al. 2009a; 
Schellenberg et al. 2011b) using primers targeting the cpn60 universal target, which were 
modified with multiplexing ID tags (MID). Amplicon sequencing was performed on the 
454 GS FLX Titanium and GS Junior sequencing platforms. Emulsion based clonal 
amplification and pyrosequencing were conducted according to manufacturer’s protocols 
(Roche, Brandford, CT). Total bacterial DNA content per swab sample was estimated 
based on quantitative PCR targeting the bacterial 16S rRNA gene using previously 
described methods (Chaban et al. 2013).  
Initial processing and quality control of raw cpn60 sequence data was performed 
using default on-rig procedures (Roche, Branford, CT). High quality reads were 
processed as previously described (Chaban et al. 2014) using the microbial Profiling 
Using Metagenomic Assembly (mPUMA) pipeline (http://mpuma.sourceforge.net) 
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(Links et al. 2013) to assemble operational taxonomic units (OTU) and to calculate OTU 
abundance with Trinity and Bowtie2, respectively. Taxonomic identification of OTU was 
accomplished through watered-Blast comparison (Schellenberg et al. 2009a) of OTU 
sequences to the cpnDB_nr reference database (downloaded on March 21, 2013 from 
www.cpndb.ca, (Hill et al. 2004)) within mPUMA. Any OTU sequence with less than 
55% identity to any reference sequence was presumed to be a non-cpn60 sequence and 
was removed from the analysis. For most analyses, OTU sequences with the same nearest 
reference database sequence were pooled as nearest neighbor "species" and their 
abundances combined accordingly. 
Detection of Mollicutes 
Mollicutes (Mycoplasma and Ureaplasma) were detected by genus-specific, 
conventional semi-nested PCR targeting the 16S rRNA gene (van Kuppeveld et al. 1992). 
The primary PCR targeted a 700 bp portion of the 16S rRNA gene using primers GPO-1 
and MGSO (van Kuppeveld et al. 1992). PCR was performed under the following 
conditions: 40 cycles of 94°C for 30 s, 64°C for 30 s, and 72°C for 60 s. The secondary 
PCR used primers My-ins (Yoshida et al. 2002) and MGSO, and 2 µl of the primary PCR 
product as template. Thermocycling parameters included 35 cycles of 94°C for 30 s, 
60°C for 30 s, and 72°C for 60 s.  
Ureaplasma species (U. parvum and U. urealyticum) were detected using a 
conventional PCR based on the multiple-banded antigen gene with primers UMS-125 and 
UMA226, which yield products of two different sizes depending on the target species: 
403 bp (Ureaplasma parvum) or 443 bp (Ureaplasma urealyticum) (Teng et al. 1995; 
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Teng et al. 1994). Specific detection of Mycoplasma genitalium was done using a 
species-specific conventional PCR targeting the 16S rRNA gene (Jensen et al. 2003).  
Mollicutes-specific 16S rRNA gene PCR amplicons from 10 samples obtained 
from 8 women were pooled and pyrosequenced as described for cpn60 amplicon 
libraries.  
Phylogenetic analysis 
For phylogenetic tree calculation, sequences were aligned with ClustalW (gap 
opening penalty = 10, gap extension penalty = 0.10) (Thompson et al. 1994). Bootstrap 
analysis was performed using 100 iterations of the sequence alignments. Distance 
matrices for the multiple sequence alignments were calculated using the F84 algorithm 
within dnadist in the PHYLIP software package (Felsenstein 1996). Phylogenetic trees 
were constructed using neighbor (Saitou and Nei 1987) and consense, and visualized 
using Dendroscope (Huson et al. 2007). 
Statistical analysis 
Demographic and clinical variables of the study cohort: These variables were 
investigated using non-parametric, descriptive statistics (IBM SPSS, version 21).  
Microbiome data: Shannon’s diversity index, Chao1 estimated number of species and 
jackknifed Bray-Curtis dissimilarity were calculated using the Quantitative Insights Into 
Microbial Ecology (QIIME) package (Caporaso et al. 2010). These indices, calculated 
from data grouped to the nearest neighbour species level, were bootstrapped 100 times at 
1000 reads per sample or their sample maximum when fewer than 1000 reads were 
available. Rarefaction plots of alpha diversity measures (Shannon’s diversity index and 
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Chao1 estimated number of species) were generated to ensure an adequate sampling 
depth for each sample had been achieved. Average linkage hierarchical clustering was 
performed based on the proportion of each nearest neighbor species per sample using the 
vegan package in R (Oksnen et al. 2012). 
 
5.4 Results 
Maternal clinical data 
Table 5.1 summarizes the demographic and clinical characteristics of 36 women 
enrolled in the study between September 2010 and December 2012. Body mass index 
(prepregnancy) was negatively correlated to the length of latency (ρs = -0.428, n = 31, p 
= 0.016).  
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Table 5.1. Demographic and clinical data for study participants (n=36). 
 
Age 32.92 ± 4.83 [22-40] 
Pre-pregnancy? BMI 23.69 ± 4.56 [17.6-37.3] 
Gestational diabetes 5 [16.1%] 
  
Ethnicity  
Asian 9 [25%] 
South Asian 1 [2.8%] 
Caucasian 20 [55.6%] 
Aboriginal 3 [8.3%] 
Other 3 [8.3%] 
  
Substance use during pregnancy  
Smoking 7 [19.4%] 
Alcohol use 4 [11.1%] 
  
Sexual history  
Marital Status  
Partnered 32 [88.9%] 
Single 4 [11.1%] 
Sexual partners during pregnancy (n=31) 1  
Vaginal intercourse during pregnancy (n=34) 31 [91.2%] 
Oral sex received during pregnancy (n=34) 11 [32.4%] 
  
Pregnancy history  
Previous pregnancy 36 [100%] 
Number of previous pregnancies (Gravida) 2.7 [1-11] 
Live birth 1.08 [0-8] 
Preterm birth 0.19 [0-2] 
  
BV and STI history during pregnancy  
Diagnosed with BV (n=34) 2 [5.9%] 
Diagnosed with yeast 7 [19.4] 
Diagnosed with UTI 6 [7.4%] 
Diagnosed with Group B Streptococcus (n=34) 2 [5.9%] 
Diagnosed with Chlamydia (n=34) 0  
Diagnosed with Gonorrhea (n=34) 0  
  
Antimicrobial use for genital tract infection 
during pregnancy (n=31) 
5 [16.1]  
  
Other  
Feminine wipes or deodorant products (n=34) 5 [14.7%]  
BMI; body mass index 
BV; bacterial vaginosis 
STI; sexually transmitted infection 
Continuous variables are reported as means ± standard deviation [range] 
Categorical variables are reported as N [%]  
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Gestational age (GA) at PPROM, latency duration, and delivery mode are 
summarized in Figure 5.1 and Table 5.2. The mean GA at PPROM was 29 weeks 
(median = 29, range 24-34), and the mean GA at delivery was 32 weeks (median = 32, 
range 25-39). The mean latency period was 18 days (median = 11, range 1-94). As 
expected, latency (days) was negatively correlated (ρs = -0.390, n = 36, p = 0.019) with 
GA at PPROM since the number of potential latency days decreases with increasing GA 
at PPROM. Since latency duration was a variable of particular interest in this study, we 
considered both absolute latency duration (<48 hours, between 48 hours and ≤ 7 days, 
and > 7 days following membrane rupture), and latency duration as a proportion of 
maximum possible latency. According to the guidelines of the American College of 
Obstetrics (2007) and Gynecologists and Society of Obstetrics and Gynecologists of 
Canada (Yudin et al. 2009), conservative/expectant management of PPROM is 
recommended for gestational ages 24 to 33 weeks and induction of labor is warranted 
after 34 weeks. Thus, the composite variable, "proportional latency", was calculated 
using the following equation: 
 









Table 5.2. Summary of PPROM to delivery timelines. 
 
 No. of women (/36) 
Gestational age at PPROM  
Extremely preterm (<28 weeks) 14 
    Very preterm (28 to <32 weeks) 17 
    Moderate preterm (32 to <34 weeks) 5 
  
Absolute latency  
<48 hours 3 
    Between 48 hours and < 7days 11 
    > 7 days 22 
  
Proportional latency1  
   0 – 0.33 15 
   0.34 – 0.66 10 
   0.67 – 1.0 11 
  
Mode of delivery   
   Vaginal delivery 24 
   Cesarean delivery 12 





Figure 5.1. GA at PPROM, latency duration and delivery mode for 36 women enrolled in the study.  
GA ranges corresponding to extremely (<28 weeks), very (28 to <32 weeks) or moderately (32 to <34 































































C = Cesarean delivery
<28 wk 28 to <32 wk 32 to <34 wk
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Proportional latency, similar to absolute latency, was negatively correlated with 
BMI (ρs = -0.511, n = 31, p = 0.003). No other significant relationships were identified 
between proportional or absolute latency and any of the characteristics reported in Table 
5.1. 
Clinical chorioamnionitis was detected in 35.5% of women (n=36, positive = 11, 
negative = 20 and data missing = 5). Histopathological chorioamnionitis was detected in 
67.7% of women (n=36, histo positive = 21, negative = 10 and data missing = 5).  
Samples for microbiome analysis 
 Over the course of study, 82 samples were obtained from 36 women and their 
infants at BC Women's Hospital & Health Centre. Vaginal samples collected within 24 
hours following PPROM and prior to administration of antibiotics were categorized as T0 
samples (time zero, n = 24). Weekly samples were collected following PPROM until 
delivery, at which time a delivery sample was collected if possible. The average number 
of samples per woman was 2 (range, 1 to 7). 
Nugent scoring 
Nugent scoring of 23 T0 samples indicated that none of the samples were 
consistent with BV (Nugent score ≥ 7 is consistent with BV). Most (73.91%, 17/23) had 
scores < 4, while 2/23 (8.7%) had intermediate scores (Nugent score 4-6), and 4/23 
(17.4%) could not be scored due to the absence of cells on the Gram stain slides. A total 
of 43 weekly samples were assessed using the Nugent scoring method, and only one of 
these had a score consistent with BV. Of the remaining samples, 13/43 (30.2%) had 
scores < 4, 25/43 (58.1%) had intermediate scores, and 4/43 (9.3%) did not have any cells 
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on the Gram stain slides. Out of the seven delivery samples, five had intermediate scores 
and the remaining two had scores of < 4. 
Total 16S rRNA and cpn60 profiles 
Total bacterial content per sample was estimated using a quantitative PCR 
targeting the bacterial 16S rRNA gene. The overall average value of log10 copy numbers 
of 16S rRNA gene for vaginal samples was 6.7. Log10 copy numbers of 16S rRNA gene 
per swab for T0 (n = 24) samples and for weekly samples (n=31) ranged between 4.4 and 
8.6, and 4.3 and 8.5, respectively. For delivery samples, log10 copies of 16S rRNA gene 
ranged between 5.0 and 8.7 per swab. The four T0 samples that could not be Nugent 
scored due to the absence of cells had log10 copy numbers of 16S rRNA gene between 4.8 
and 6.0. Estimates of total 16S rRNA gene copies in swabs from T0 samples (mean =6.65 
log10 copies per swab) were significantly different (independent T test, t = 5.944, df = 
103) from values obtained from 100 clinically healthy pregnant women at low risk for 
preterm birth (mean = 8.14 log10 copies per swab), which were estimated using the same 
sample preparation and quantitative PCR method (unpublished data). 
For the 70 vaginal swab samples available for cpn60-based microbiome profiling, 
an average of 12,675 cpn60 sequence reads were obtained per sample (range 36 - 99, 
358; median 6,296). One sample (week 2 sample from woman 60) that yielded only 36 
sequence reads was excluded from statistical analyses. Rarefaction analysis of alpha 
diversity measures (Shannon’s diversity index and Chao1 estimated number of species) 
indicated that all other samples had received adequate coverage for inclusion in further 
analysis. Shannon’s diversity index and Chao1 diversity of T0 samples were not 
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significantly different between proportional latency and absolute latency groups as 
defined in Table 5.2 (Kruskal-Wallis, p > 0.05).  
A total of 718 OTUs were detected in 82 samples (70 vaginal samples and 12 
neonate skin microbiome samples). Of the 670 OTUs detected in the vaginal samples, 9 
OTUs accounted for more than 50% of sequence reads obtained. When OTUs were 
classified according to their nearest neighbour in cpnDB_nr, 20 nearest neighbour taxa 
(each accounting for at least 1% of the total sequences obtained in the study) accounted 
for 77% of the data (Table 5.3). The most abundant OTU accounted for 12.4% of the 
sequence reads, was 97.1% identical to Prevotella timonensis JCM 15640 (Table 5.3) and 
was detected in 34/36 women (64/70 samples).  
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Table 5.3. Prevalence of nearest neighbour species accounting for at least 1% of the total sequence 
reads in the study. 
 









of data (%) 
Megasphaera sp. UPII 199-6 1 99.6 36 70 3.0 
Lactobacillus iners DSM 13335 2 93.9-99.3 36 60 8.8 
Lactobacillus	  crispatus	  CECT4840 2 95.3-­‐99.8 35 62 5.8 
Prevotella timonensis JCM 15640 1 97.1 34 64 12.4 
Gardnerella vaginalis 409-05 (Group A) 2 88.8-99.5 31 51 11.3 
Escherichia coli KTE143 1 99.1 31 50 1.8 
Lactobacillus jensenii ATCC 25258 2 98.9-99.2 30 43 4.2 
Corynebacterium accolens ATCC 49725 4 91.2 29 59 2.6 
Gardnerella vaginalis ATCC 14018 (Group C) 1 99.5 29 48 3.0 
Streptococcus pseudopneumoniae ATCC BAA-960 3 94.2-94.4 29 45 2.6 
Alloscardovia omnicolens LMG 23791 1 97.3 27 46 3.6 
BVAB2 2 99.6-99.8 27 38 1.38 
Prevotella bivia JCM 6331 1 99.1 25 50 2.6 
Peptoniphilus harei ACS-146-V-Sch2b 4 73.6-98.6 25 45 1.3 
Corynebacterium striatum ATCC 6940 1 94 22 47 1.4 
Bifidobacterium infantis 6w-50 1 99.3 22 35 2.5 
Actinomyces sp. 4 74.1-100 21 36 2.7 
Streptococcus oralis ATCC 35037 2 88.7-93.8 17 25 1.0 
Prevotella veroralis ATCC 33779 1 98.2 15 27 3.1 




Average linkage hierarchical clustering of T0 microbiome profiles (n = 24) was 
conducted based on nearest neighbour taxa constituting at least 10% of the microbiome in 
at least one sample (Figure 5.2). The microbiome profiles clustered into profile types, 
each dominated by one or two species including Lactobacillus crispatus, Lactobacillus 
iners, Prevotella timonensis, G. vaginalis, Corynebacterium sp. and Escherichia coli 
(Figure 5.2). Half (12/24) of T0 samples were dominated (≥50% of the microbiome) by 
one or more species of Lactobacillus. In eight of these cases, a single Lactobacillus sp. 
comprised at least 50% of the microbiome: L. crispatus (n=4), L. iners (n=3) and L. 




Figure 5.2. Average linkage hierarchical clustering of cpn60 based microbiome profiles of T0 vaginal 
samples from 24 women.  
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Microbiome profiles did not cluster based on GA at PPROM, latency (absolute 
latency category or proportional latency), or chorioamnionitis (clinical or 
histopathological) (Figure 5.2). 
Core microbiome and highly prevalent organisms 
An OTU sequence (comp15864_c0_seq1) with 99.6% identity to Megasphaera 
sp. UPII 199-6, a type I Megasphaera (cpndb ID: b19134, GenBank accession 
AFIJ01000035), was detected in all 70 vaginal samples and all 12 infant skin samples 
(comprising 0.0076% to 22.6% of individual microbiome profiles). OTU sequences with 
best matches to any Megasphaera sp. were combined with reference sequences to 
construct the phylogenetic tree shown in Figure 5.3. Four additional OTU sequences 
clustered with Megasphaera micronuciformis F0359, Megasphaera elsdenii, and 
Megasphaera sp. BV3C16-1. One OTU sequence (comp15950_c5_seq1) that was 
detected in three women had less than 80% identity to any reference cpn60 sequence and 




Figure 5.3. Phylogenetic tree of Megasphaera-like study sequences (represented by circles, n=6) 
combined with Megasphaera reference sequences.  
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OTU sequences identical to L. iners DSM 13335 (cpndb ID: b15282, GenBank 
Accession: ACLN01000008) were detected in all T0 samples (n=24). In three of these 
samples, L. iners was the dominant species, accounting for >50% of the total reads.  
Prevotella spp. were detected in all vaginal samples, and were also dominant 
(accounting for ≥50% of reads) in 1/24 T0 samples and 10/46 weekly samples. Fourteen 
different species of Prevotella were detected in the T0 samples (with identification based 
on >95% sequence identity to the reference sequence), along with 15 other Prevotella-
like OTU sequences with weaker (80-95%) similarity to reference sequences. The most 
prevalent species were P. timonensis and P. bivia, which were detected in 92% and 42% 
of T0 samples, respectively. Taken together, OTU sequences with affiliation to Prevotella 
were detected in all T0 samples. In addition to the 29 OTU sequences that were detected 
in T0 samples, seven additional Prevotella-like OTU sequences were detected in weekly 
or delivery vaginal samples. Prevotella-like OTU sequences were combined with 
Prevotella reference sequences for phylogenetic analysis (Figure 5.4). In addition to the 
OTU sequences that were closely affiliated to known species, 15 OTU sequences did not 




Figure 5.4. Phylogenetic tree of Prevotella-like study sequences and Prevotella reference sequences.  
Study sequences detected in T0 samples are indicated by triangles. Sequences represented by circles were 
detected only in weekly or delivery vaginal samples. The tree is based on a 300 bp alignment. Only 28 of 
the 36 identified Prevotella-like OTU could be included in the tree since the remaining sequences did not 
provide sufficient overlap to be included in the alignment. Bootstrap values (>50%) are indicated at node. 
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Mollicutes (Mycoplasma and/or Ureaplasma) were detected by PCR in 81% 
(29/36) of women (Table 5.3). A woman was considered positive for Mollicutes if any 
one or more of her samples was found positive by PCR.  
Ureaplasma spp. were detected in 53% (19/36) of women, with Ureaplasma 
parvum detected in 39% (14/36) and Ureaplasma urealyticum detected in 17% (5/36) of 
women. Both species were detected together in only one sample. When only T0 samples 
were considered, 24/36 (66.7%) were PCR positive for Mollicutes. Non-parametric 
statistics were used to determine the relationships of proportional latency, absolute 
latency and GA at birth with Mollicutes detection. Both proportional latency and absolute 
latency were significantly shorter in women whose T0 samples were PCR positive for 
Mollicutes compared to women who were Mollicutes negative (Figure 5.5A, 5.5B), and 
women whose T0 samples were positive for Mollicutes had significantly lower GA at 





Figure 5.5. Proportional latency (A), absolute latency (B), GA at birth (C) and infant birthweight (D) 
for women with Mollicutes PCR positive or negative T0 vaginal samples. 
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To investigate the species of Mollicutes in these samples more thoroughly and to 
determine if any novel or unexpected species were present, Mollicutes-specific 16S 
rRNA secondary PCR products from 10 samples (representing 8 women) were pooled 
and sequenced, resulting in 28,278 high quality sequence reads. All sequence reads were 
classified (93.7 to 99.1% identical to the reference sequence) as Mycoplasma hominis, 
Ureaplasma parvum or Ureaplasma urealyticum. None of the reads were classified as M. 
genitalium, and all samples subsequently tested negative by Mycoplasma genitalium 
species-specific PCR, suggesting that M. genitalium was not present at detectable levels 
in these women. Although the Mollicutes-specific primer set is reported to amplify some 
Firmicutes (Chaban et al. 2014), only four reads were identified as non-Mollicutes (97-
98% identical to L. iners). 
Instability of the vaginal microbiota over the latency period  
Figure 6 illustrates changes in vaginal microbiome profiles in the weeks following 
PPROM. All women received one or more broad-spectrum antibiotics (Ampicillin, 
Erythromycin, Amoxicillin, Metronidazole, Clindamycin, Cefazolin, Nitrofurantoin, 
and/or Penicillin G). The number of different antibiotics administered to any individual 
woman during the course of latency ranged from 1 to 7. In all women for whom multiple 
samples were available, the apparent composition of the vaginal microbiota changed 
dramatically over the latency period (Figure 5.6). In 4/5 cases where Lactobacillus was 
dominant in the T0 microbiome, its proportional abundance had decreased substantially 
by the subsequent sample time point (women 42, 34, 60, 48). The exception to this 
pattern was woman 51, whose microbiome was dominated by L. jensenii and L. iners at 
T0 and at week 1. Eight of the 19 women for whom multiple samples were available, had 
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one or more samples dominated (≥50% of the microbiome) by Prevotella spp. (Figure 
5.6). Of the remaining 11 women, five of them had Prevotella spp. as the proportionally 




Figure 5.6. Vaginal microbiome profiles over the post-PPROM latency period.  
Data is presented as proportion of the total sequence reads obtained for each sample, with the height of the 
ordinate corresponding to 100%. Sampling times are indicated with vertical broken lines, and collection 
time (weeks) for each sample is indicated on the abscissa. Samples indicated as collected at "0+" were 
collected within 3 days following PPROM, but were post-antibiotic treatment. Sample identification 
numbers appear in the upper left corner of each panel. The legend includes nearest neighbour species that 
account for at least 10% of the sequence reads in at least one sample. 
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In addition to the graphical analysis in Figure 5.6, instability of the vaginal 
microbial community was described quantitatively using the Bray-Curtis dissimilarity 
index. For women with PPROM, ecological distance between samples within individuals 
(mean = 0.79, median = 0.86, range = 0.16 - 0.99) was significantly lower (ANOVA, F1, 
1828 =21.04, p =0.002) than distances between samples from different women (mean = 
0.88, median = 0.93, range = 0.10 - 1.00) (Figure 5.7). However, when the PPROM 
cohort was compared to a cohort of healthy, non-pregnant women who were sampled 
weekly throughout a menstrual cycle (Chaban et al. 2014), the distance between samples 
within individuals in the PPROM cohort was significantly greater (ANOVA, F1, 112 = 
95.78, p < 0.0001) than the average distance for samples within individuals in the 
healthy, non-pregnant cohort (mean = 0.29, median = 0.13, range = 0 - 0.98), indicating 
the greater instability of the PPROM associated microbiomes. These analyses should be 





Figure 5.7. Box and whisker plot representing Bray-Curtis distances. 
Bray-Curtis distances between vaginal microbiome profiles of women with PPROM, and clinically healthy, 


























Table 5.5 summarizes neonatal outcomes. Four babies (4/36, 11.1%) were small 
for gestational age (<10th percentile). Infants born to women whose T0 samples were 
positive for Mollicutes had significantly lower GA at delivery and correspondingly lower 
birth weight than those born to women with Mollicutes negative T0 samples (Figure 5C 
and 5D). Apgar score at 1 minute was positively correlated to gestational age at delivery 
(ρs = 0.631, n = 35, p = 0.0001), as was Apgar score at 5 minutes (ρs = 0.592, n = 35, p = 
0.0001). Since Apgar scores are not usually very evenly distributed, it was categorized 
into two: <7 and 7-10 and it was found that gestational age at delivery for <7 Apgar score 




Table 5.5. Neonatal outcomes. 
Gender  
Male 25  
   Female 11 
  
Birth weight (grams) 1812.9 [570 – 3410] 
   Extremely low birth weight (<1000 g) 6 [16.7%] 
   Very low birth weight (<1500 g) 4 [11.1%] 
   Low birth weight (<2500 g) 20 [55.6%] 
   Normal  6 [16.7%] 
  
Small for gestational age (n=35)  
Moderate (<10th percentile) 2 [5.7%] 
Severe (<3rd percentile) 2 [5.7%] 
  
Bronchopulmonary dysplasia (n=32)  
   None 23 [71.8%] 
   Mild 4 [12.5%] 
   Severe 3 [9.4%] 
  
Apgar 1 minute score 5.9 [1- 9] 
  
Apgar 5 minute score 7.8 [3-10] 
  
MAIN score 563.2 [0 - 1878] 
  
NICU admission (n=34) 
Days of stay in NICU 
23 [68] 
24.57 [0.81 – 137.74] 
Continuous variables are reported as means ± 95% CI [range] 
Categorical variables are reported as N [%] 
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In 11/12 infant skin microbiome profiles, Proteobacteria was the dominant 
phylum. In the remaining sample, an OTU with 94.2% identity to Streptococcus 
pseudopneumoniae dominated the microbiome. The most prevalent and abundant OTU 
detected in the skin microbiome of infants included those with similarity to Escherichia 
coli (99.1% identity, 11/12), Pseudomonas extremaustralis (95.7% identity, 12/12), 
Rhodococcus erythropolis (100% identity, 12/12), Streptococcus pseudopneumoniae 
(94.2% identity, 8/12), Acidovorax sp. (94.1% identity, 12/12), G. vaginalis group C 
(99.1% identity, 5/12), Prevotella bivia (99.1 % identity, 8/12), and Prevotella timonensis 
(97.1% identity, 12/12). Sequences corresponding to vaginal microbiome associated 
organisms Megasphaera sp. Type 1 (99.6% identity, 12/12), Lactobacillus crispatus 
(99.8% identity, 12/12) and L. iners (99.3% identity, 11/12) were also highly prevalent, 
but abundance was low (<2% of any individual infant skin microbiome). Mollicutes were 
detected in 33% (4/12) of the infant skin samples, with two samples PCR positive for 
Ureaplasma parvum and one PCR positive for Ureaplasma urealyticum. 
Comparisons of vaginal microbiome profiles and infant skin microbiome profiles 
for 12 mother-infant pairs are shown in Figure 5.8. In each case, the vaginal sample 
obtained closest to delivery was chosen for comparison. For 7 out of 12 mother-infant 
pairs, which includes two cases where delivery was by C-section, the Bray Curtis 
distance between samples was less than 0.79 (the mean Bray Curtis distance between 




Figure 5.8. Paired maternal vaginal microbiome profiles and infant skin microbiome profiles.  
Data is presented as proportion of the total sequence reads obtained for each sample, with the height of the 
ordinate corresponding to 100%. Days pre-delivery and post delivery are indicated on the abscissa. The day 
of delivery is indicated with "D". Maternal sample identification numbers appear above each panel. Bray-
curtis distances between vaginal sample profile and corresponding infant skin profile are indicated below 
each panel. The legend includes nearest neighbour species that account for at least 10% of the sequence 
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All but one of the infants born to the women enrolled in the study survived. One 
infant, delivered vaginally at 25 weeks after a three-day latency period (birth weight 570 
g), died of late onset sepsis at 46 days of life. Blood culture of the infant tested positive 
for E. coli at 12 days of life. E. coli was present in the vaginal microbiome of mother (T0 
vaginal sample, detected at level of 0.02% of the total microbiome). The microbiome of 
the mother had L. iners as the most dominant species (32% of reads), followed by G. 
vaginalis. The vaginal T0 sample tested positive for Mollicutes, and was found to be 
positive for Ureaplasma urealyticum. No infant skin microbiome sample was collected. 
5.5 Discussion 
Imbalances in the complex microbial community residing in the vagina have been 
associated with late miscarriages (gestation ages between 16 - 24 weeks) (Hay et al. 
1994), preterm delivery (Foxman et al. 2013; Hillier et al. 1995; Holst et al. 1994; 
Martius et al. 1988) and PPROM (Gravett et al. 1986; Joesoef et al. 1995). Disturbed 
vaginal microbiota is also correlated to neonatal morbidity and adverse maternal 
outcomes such as clinical chorioamnionitis, postpartum endometritis and wound 
infections (Gravett et al. 1986; Jacobsson et al. 2002; Mass et al. 1999; Zhang et al. 
2002). However, little is known about characteristics of the vaginal microbiome during 
the latency period following PPROM, a critical period during which interactions with the 
genital tract microbiota likely contribute to both maternal and fetal outcomes. 
A total of 36 women with PPROM were enrolled in the study. However, initial 
samples for 12 of these women were collected >24 hours following membrane rupture 
and after the administration of antibiotics, which left 24 T0 samples for analysis in 
addressing the question of whether the vaginal microbiome structure at time of PPROM 
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predicts latency duration. Hierarchical clustering of T0 profiles based on sequences 
comprising at least 10% of the microbial profile of at least one woman did not reveal any 
associations between microbiome profile and gestational age at PPROM, latency 
duration, or development of chorioamnionitis (Figure 5.2). The results of the study do not 
provide support for the vaginal microbiome profile at time of membrane rupture as a 
predictor of latency duration; however the analysis of weekly samples collected during 
the latency period revealed a remarkably unstable, abnormal microbiome.      
BV has been identified as a risk factor for preterm birth and PPROM (Epstein et 
al. 1998; Hillier et al. 1995). In the current study, none of the samples collected within 24 
hours of membrane rupture (T0 samples) had Nugent scores consistent with BV, including 
four that had no cells on the slide. Amniotic fluid leaking after membrane rupture may 
have dislodged some of the resident microbiota, resulting in reduced numbers of bacteria 
available for scoring. Lower 16S rRNA copy numbers detected per vaginal swab in T0 
samples in comparison to those detected in swabs from healthy pregnant women supports 
this explanation. It is also possible that amniotic fluid increased the pH of the vaginal 
sample collected for Gram staining, which can decrease the efficacy of the stain 
(Lamanna and Mallette 1954). Samples that did not have sufficient numbers of cells for 
Nugent scoring did provide adequate genomic DNA template for cpn60 universal target 
profiling, illustrating the relatively low limit of detection of PCR compared to 
microscopy. A lack of consistency of T0 microbiota with BV was also apparent in the 
sequence-based profiles, with few of the microbiome profiles of T0 samples dominated 
by G. vaginalis (5/24) or Atopobium vaginae (0/24), which are strongly associated with a 
Nugent score diagnosis of BV (Figure 5.2) (Menard et al. 2008; Romero et al. 2014a). 
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BVAB (BV associated bacteria) are another group of organisms, recently described as 
being associated with BV (Fredricks et al. 2005; Oakley et al. 2008). Three OTUs were 
detected with BVAB3 and BVAB2 as nearest neighbour, but no samples in this study 
were dominated by these sequences, with no sample containing more than 15.7% BVAB. 
Only half of the T0 samples had profiles dominated by Lactobacillus (Figure 2). 
Among these, samples dominated by L. crispatus (n=4) were outnumbered by those 
dominated by L. iners, either alone or in combination with L. jensenii. In fact, L. iners 
was detected in all T0 samples, although it comprised >50% of the microbiome in only 
four cases. L. iners is associated both with normal and BV microbiota, and is also 
reported as a dominant organism when the vaginal microbiota is in a transition state, 
either from normal to BV or vice versa (Jakobsson and Forsum 2007; Santiago et al. 
2012; Verstraelen et al. 2009), and L. iners dominated microbiomes have been associated 
with spontaneous preterm birth (Petricevic et al. 2014). The hemolytic and mucinolytic 
potential of L. iners could be involved in its survival during disturbed vaginal conditions, 
and also may be suggestive of its pathogenic potential (Macklaim et al. 2011).  In 
contrast, longitudinal stability of the vaginal microbiota in pregnant women with term 
deliveries has been associated with L. crispatus dominated profiles (Romero et al. 
2014a). While it is possible that more of the women in the study had Lactobacillus 
dominated microbiota immediately prior to PPROM, these bacteria would have had to 
have been selectively reduced to extremely low or even undetectable levels in the 
microbial community due to amniotic fluid leakage or some other factor within 24 hours 
of membrane rupture. 
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Prevotella spp. were detected in all samples from all women in this study, and 
sequences from this genus dominated some profiles either at T0 or at subsequent time 
points during latency (Figure 5.2 and Figure 5.6). In contrast, in a cpn60-based study of 
91 vaginal samples from clinically healthy, non-pregnant, Canadian women, Prevotella 
were detected in only 57% of samples, with the most frequently detected species (P. 
timonensis) present in only 45% of samples (Chaban et al. 2014). Prevotella have been 
detected in 62-96% percent of samples in two recent studies of the vaginal microbiota of 
non-pregnant, reproductive aged women with a range of Nugent scores, but the particular 
species within this genus could not be resolved using 16S rRNA sequence data (Ravel et 
al. 2011; Shipitsyna et al. 2013). cpn60 universal target sequences have been 
demonstrated to provide superior resolution of Gram negative anaerobic rods, including 
Bacteroides and Prevotella (Sakamoto and Ohkuma 2010). In the current study, we 
identified 14 known species and 15 additional, possibly novel Prevotella spp. (Figure 
5.4). Given the suggested role of Prevotella spp. in synergistic relationships with BV 
associated organisms (Pybus and Onderdonk 1997, 1998) and their production of 
lipopolysaccharide in the vaginal environment (Aroutcheva et al. 2008), the prevalence 
and diversity of Prevotella spp. in the PPROM associated vaginal microbiota clearly 
warrants further investigation. 
OTU sequences corresponding to Megasphaera type 1 were also detected in all 
samples examined. Megasphaera spp. were first reported to be part of the vaginal 
microbiome in 2004 (Zhou et al. 2004), and Megasphaera type 1 has since been strongly 
associated with BV (Datcu et al. 2013; Zozaya-Hinchliffe et al. 2008). Two OTU 
sequences clustered with Megasphaera micronuciformis F0359 (99-100% sequence 
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identity), an obligate anaerobe isolated from the human oral cavity as a part of the Human 
Microbiome Project (Figure 5.3). Identification of bacterial species associated with the 
oral microbiome in the amniotic fluid of women who experience preterm birth has been 
observed previously, although the significance of this relationship and whether it is 
indicative of transfer of organisms is not known (Gauthier et al. 2011; Hill 1998). 
 Genital Mycoplasma and Ureaplasma have been strongly associated with adverse 
maternal and fetal outcomes (Goldenberg et al. 1998; Taylor-Robinson and Lamont 
2011; Waites et al. 2005), and cervical colonization of genital mycoplasmas is associated 
with preterm birth and PPROM (Kacerovsky et al. 2009; Wasiela et al. 2003). These 
organisms have also been isolated from amniotic fluid and chorioamnion of women with 
PPROM and preterm labor (Kim et al. 2009; Wang et al. 2013). Since cpn60 genes are 
known to be absent in some Mollicutes (Clark and Tillier 2010), genus and species 
specific PCR was used to detect these organisms. Eighty percent of women in the study 
were found to be PCR positive for Mycoplasma and/or Ureaplasma, which is at the 
higher end of the range reported in pregnant women (10-84%) (Bayraktar et al. 2010; 
Grattard et al. 1995; Larsen and Hwang 2010; Paul et al. 1998). No M. genitalium was 
detected in any of the women in the study, either by pyrosequencing of Mollicutes 16S 
rRNA amplicons, or by species-specific PCR. M. genitalium is strongly associated with 
urethritis in men and cervicitis and infertility issues in women (Larsen and Hwang 2010). 
However, its role seems to be more of a cervicitis pathogen (Gaydos et al. 2009; Pepin et 
al. 2005) contributing to infertility similar to Chlamydia trachomatis rather than as part 
of an endogenous microbiota contributing to adverse pregnancy outcomes. Hence in 
some studies, presumably in populations with low rates of cervicitis, they either did not 
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detect the species in amniotic fluid or were not able to demonstrate any associations with 
adverse pregnancy outcomes (Cazanave et al. 2012; Larsen and Hwang 2010). In the 
current study, the presence of vaginal Mollicutes was associated with significantly lower 
APGAR scores, lower GA at delivery, and correspondingly lower birth weight, 
supporting previous suggestions of a potential role for these organisms in adverse 
pregnancy outcomes. However, small sample size precluded a statistical analysis of the 
association of individual species of Mollicutes with these outcomes. 
Antibiotic administration in women with PPROM at less than 32 weeks has been 
shown to decrease neonatal morbidity and prolong pregnancy (Yudin et al. 2009), and all 
women in this study were treated with antimicrobials according to current clinical 
guidelines. All women were also administered corticosteroids: betamethasone and/or 
dexamethasone, for the purposes of promoting fetal lung maturation. Antibiotic and 
steroid administration may have contributed to the microbiome profiles observed meeting 
the definition of mixed abnormal or intermediate vaginal microbiota or even aerobic 
vaginitis (E. coli dominated) (Donati et al. 2010; Donders 2007; Donders et al. 2002), 
rather than Lactobacillus dominated or BV. Another potential contributor to the observed 
abnormal microbiota is the leakage of amniotic fluid (pH 7 to 7.5) (Davidson 1991) 
through the normally acidic vaginal environment. These disruptive factors likely 
contributed to the observation that women whose vaginal microbiota was dominated by 
Lactobacillus immediately following PPROM (women 29, 34, 42, 48, 51 and 60, Figure 
5.6), rapidly transitioned to an abnormal microbial profile.  
Perhaps the most striking observation in this study was the highly unstable nature 
of the vaginal microbiota over the latency period (Figure 5.6, 5.7). The results of the 
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graphical analysis of the microbial profiles and the quantitative assessment of ecological 
distance between samples within and between women are in stark contrast to the 
generally stable microbial community observed in longitudinal studies of healthy, non-
pregnant (Chaban et al. 2014; Gajer et al. 2012; Hickey et al. 2012) and pregnant women 
(Romero et al. 2014a). The current study did not assess the stability of the vaginal 
microbiota in these women prior to PPROM, and so it cannot be determined if as a group 
they had a more or less stable microbiota prior to PPROM. It has been suggested that 
stability in terms of maintenance of a core set of metabolic capabilities of the human 
microbiome is correlated to health, even when the community structure varies in its 
taxonomic composition (Consortium 2012). The instability reported in this study is in 
terms of phylogenetic or taxonomic composition, not functional capacity. However, if 
stability is an important factor for health, then the highly unstable microbiome observed 
following PPROM needs to be studied further using metagenomic and metabolomics 
approaches, to gain a more complete understanding of the relationship of microbiome 
dynamics and maternal and fetal outcomes, especially long term outcomes following 
membrane rupture. 
In 12 cases, the neonatal skin microbiome was characterized and compared to the 
vaginal sample closest to delivery (Figure 5.8).  Detection of vaginal microbiota on infant 
skin is hardly surprising in cases of vaginal delivery, but similar organisms were also 
detected in the skin microbiomes of three infants delivered by C-section. This could be 
due to ascension of bacteria from the lower genital tract either before or after membrane 
rupture. Vaginal bacteria such as Gardnerella, Megasphaera, Prevotella, 
Porpyhromonas, and Ureaplasma have been recovered from the meconium of infants 
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delivered either by C-section or vaginally, suggesting possible exposure of the fetus to 
the maternal microbiota during gestation as well as during delivery (Datcu et al. 2013).  
Taken together, the results of this study provide an unprecedented 
characterization of the vaginal microbiota following PPROM, and support previous 
suggestions of a role for Mollicutes in adverse pregnancy outcomes associated with 
PPROM. These results also clearly demonstrate the value of application of culture-
independent methods for microbial profiling, especially where the nature of the available 
samples precludes application of techniques such as microscopy and culture, or severely 
limits their utility. The highly unstable and abnormal vaginal microbiota of the women in 
this study demonstrates the need for more intense study of the relationship of genital tract 
microbiota with PPROM, including functional analysis of these microbial communities. 
Future work should involve larger studies including sampling before and after membrane 
rupture, and also after delivery, to determine if the composition of the microbiota is 
abnormal or unstable prior to membrane rupture, and whether the community achieves a 
healthy state following cessation of antibiotic therapy.  
Acknowledgements 
This work was funded by a March of Dimes Prematurity Research Initiative grant 
awarded to DMM [MONEY 21-FY08-537]. TPJ was supported by a University of 
Saskatchewan Graduate Scholarship. The authors are grateful to Bonnie Chaban for 
helpful discussion and advice in data analysis. The authors wish to thank the clinicians 
and laboratory staff at BC Women’s Hospital and Health Centre and their patients for 
their important contributions to this study.  
  
 163 
CHAPTER 6 -  General Discussion and Conclusions  
6.1 Summary and limitations of these works 
Gardnerella vaginalis can be resolved into four subgroups that likely represent different 
species. 
Using cpn60 UT sequence, G. vaginalis could be resolved into four subgroups. 
Upon inspection of the whole genome sequences of isolates of G. vaginalis of four 
subgroups using inter-genome similarity comparing algorithm ANIm, it was found that 
the four groups meet the suggested criterion for a molecular definition of bacterial 
species (Richter and Rossello-Mora 2009). The whole genome based analysis reported by 
Ahmed et al. (2012) also describes four clades within the genus Gardnerella and results 
presented in this thesis have shown that the four clades described by Ahmed et al are the 
same as the four cpn60 subgroups that I have described. Proteomic profiles of isolates of 
each subgroup formed unambiguous clusters supporting the cpn60 UT based and Ahmed 
et al. based categorization of the genus. 
Determination of the Piot biotypes (1984) of G. vaginalis isolates was not useful 
in defining subgroups as there was no congruence between cpn60 subgroups and Piot 
biotypes. However, ß-galactosidase activity, one of the phenotyping assays included in 
Piot biotyping, was found to be only exhibited by subgroup C G. vaginalis isolates. 
Similarly, antimicrobial susceptibility testing of available G. vaginalis isolates was not 
useful in discriminating subgroups. 
One of the limitations of this part of research is that with more cpn60 sequences 
being added for the phylogenetic analysis presented in Chapter 3 than were included in 
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our original study (Chapter 2), an outlier group has been identified. Our current culture 
collection of G. vaginalis does not include any isolates belonging to this outlier group 
and so I was unable to investigate properties of these isolates. One of the other drawbacks 
is that there is only one isolate in our culture collection from subgroup D, which limits 
my ability to draw strong conclusions about this subgroup. A previous metagenomic 
study (Chaban et al. 2014) of vaginal microbiome of healthy reproductive aged women 
indicates that subgroup D is rare. Subgroup D G. vaginalis is also observed to be rare in 
healthy reproductive aged pregnant and non-pregnant Canadian women (n=500) profiled 
as part of the ongoing work of our research team (Vogue Research Team, Unpublished). 
Collecting more isolates of this subgroup and investigating phenotypic and genotypic 
properties will help provide evidence to support likelihood of subgroups being different 
species. 
Clinical significance of subgroup B Gardnerella vaginalis is demonstrated by the 
presence of sialidase enzymatic activity and its differential distribution in Kenyan women 
Subgroup B G. vaginalis stands out from the rest of the subgroups in terms of a 
few clinically significant factors. Sialidase activity, which is associated strongly with BV, 
is one characteristic that can be used to discriminate subgroup B from the rest. Another 
observation of clinical significance comes from the observation of differential 
distribution of subgroup B isolates in a cohort of Kenyan women. Subgroup B G. 
vaginalis was significantly more abundant in women categorized as having BV than not. 
Also, the fascinating observation of anaerobic isolates of subgroup B also makes them 
interesting and important candidates for consideration while developing better diagnosis 
of BV. 
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While describing the clinical significance of subgroup B, it is important to be 
cautious as the distribution of G. vaginalis subgroups in many more cohorts needs to be 
understood before concluding anything about the clinical significance of this subgroup. 
Similarly, sialidase is so far the only virulence factor that distinguishes subgroup B from 
others. There are many other important virulence factors such as prolidase and 
vaginolysin that need to be further characterized in isolates within the four subgroups. 
This in turn will help understand any other factors that might distinguish subgroups as 
well as improving understanding of the clinical significance associated with these 
subgroups. The potential clinical significance of anaerobic isolates of subgroup B G. 
vaginalis needs to be explored further given the suggested role of G. vaginalis as a “stage 
setter” for BV. 
One of the major limitations of this work is that genome content differences 
between anaerobic and facultative strains of G. vaginalis have not been characterized 
beyond predicting functions based on genome annotation. These genomic fragments 
require additional characterization and validation in terms of function.  In addition to that, 
both isolates that exhibited an anaerobic phenotype (N153 and N101) were isolated from 
the same woman. Though it is reported in the literature that anaerobic isolates of 
Gardnerella are rare, further efforts are required to isolate anaerobic strains of 
Gardnerella from different women, possibility even from different cohorts. Anaerobic 
isolates of G. vaginalis were only detected in subgroup B, but more isolates of other 
subgroups need to be characterized and investigated for the presence of anaerobic isolates 
to determine if anaerobic lifestyle is a subgroup B specific characteristic. 
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Overall microbial profiles at membrane rupture in women with PPROM did not predict 
clinical outcomes 
The prospective study of the vaginal microbiota following preterm premature 
rupture of membranes resulted in an unprecedented characterization of the vaginal 
microbial community structure of these women immediately after membrane rupture and 
also during their latency period. Skin microbiomes of neonates born to these women were 
also characterized and described in terms of species present and their adundance. 
Although the vaginal microbiome has been studied numerous times by researchers 
around the world for the past many decades, the vaginal microbial community after 
membrane rupture has to our knowledge never been described. Characterizing the vaginal 
microbiome immediately after membrane rupture, and through latency until delivery is a 
great addition to the wealth of information that we have specifically about the condition 
of PPROM, and more information regarding the same might help clinicians better 
manage this potentially devastating condition.  
It was found that microbiome profiles immediately after membrane rupture were 
generally dominated by one or two species including Lactobacillus crispatus, L. iners, 
Prevotella timonensis, Prevotella bivia, G. vaginalis, and Escherichia coli.	  The vaginal 
microbiota was found to be highly unstable over the latency period, with dramatic shifts 
in composition between weekly samples. There was an overall decrease in Lactobacillus 
abundance as weeks advanced in the latency period. Mollicutes (Mycoplasma and/or 
Ureaplasma) were detected by conventional PCR in 81% of women. Adverse pregnancy 
outcome were correlated with detection of Mollicutes as these women with Mollicutes 
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had significantly lower GA at delivery and correspondingly lower birth weight infants 
than Mollicutes PCR negative women. 
 This prospective study has helped generate many testable hypotheses that should 
be followed up on future studies. One such hypothesis is that Megasphaera and 
Prevotella comprise a core microbiome in women with PPROM. Higher abundance and 
prevalence of Lactobacillus iners in these women and its association with microbiome 
instability and transition needs to be carefully questioned in future studies. 
One of the major limitations of this study was the sample number. Only 36 
women were included in the microbiome analyses, a number that does not power us 
statistically to make strong correlations and hence hampers making concrete conclusions. 
It remains to be determined if the lack of prediction of latency duration based on 
microbiome profile at time of membrane rupture was due to the study being 
underpowered. This cohort presents many challenges in terms of patient enrolment and 
sampling, and we experienced many sampling problems, both in terms of having few 
samples being collected (low study enrolment rates) and insufficient quantities of 
amplifiable DNA in each sample (which is likely due to having collected vaginal samples 
after the flush out of microbial community by the amniotic fluid following membrane 
rupture). At the end of enrolment, we had 62 women enrolled for the study. However, 
due to issues with previously used sampling protocols based on the DNAzol Direct 
method, samples from 22 women were rendered useless as they had insufficient 
quantities of amplifiable DNA. Adoption of new sample collection and processing 




6.2 Discussion of future prospects 
Species level resolution required to make clinical associations 
A species in the microbial world is currently defined by a polyphasic approach 
based on genotypic and phenotypic properties using techniques from microbial 
systematics, ecology, genomics and evolutionary biology. Species resolution is critical in 
microbiome studies where microbiome structure and patterns associated with clinical 
outcomes could lead to important diagnostic procedures. Average nucleotide identity 
based on whole genome sequences is replacing the gold standard method for defining 
species, which is DNA-DNA hybridization. In metagenomic studies, microbial diversity 
is usually described using operational taxonomic units (OTUs) based on 16S rRNA gene 
sequences. However, 16S rRNA provides only limited resolution and helps in 
discriminating microbes in many cases only to genus level. The cpn60 universal target is 
demonstrated to provide high-resolution microbiome profiles (Chaban et al. 2014; Hill et 
al. 2005a; Schellenberg et al. 2011a; Schellenberg et al. 2009b) and has been proven to 
be an effective tool in predicting genome similarity and for species determination 
(Verbeke et al. 2011). 
 In Chapters 2 and 3, I have demonstrated the ability of cpn60 to resolve the 
heterogeneity within the genus Gardnerella. There are other taxa that may benefit from 
closer examination and potential sub-speciation using these methods. Examples of such 
taxa include Megasphaera and the BVABs since their positive association with BV and 
high specificity for diagnosing BV make them very important taxa that require urgent 
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investigation. Currently, Megasphaera are rarely reported at higher resolution than genus, 
and the lack of cultured isolates of BVAB1 and BVAB2 has meant that they are reported 
solely on the basis of 16S rRNA sequence detection. In some instances, resolution greater 
than species is a requirement. For instance, Lactobacillus iners is an important taxon of 
vaginal microbiota, noted for its presence when the microbiome is in transition state. L. 
iners is also routinely detected in the healthy microbiome and is often a dominant 
member of healthy vaginal microbiota. In the PPROM cohort, two OTUs corresponding 
to L. iners were detected. Such strain level resolution needs to be further inspected in 
other cohorts and studied to understand any clinical significance that might be present for 
the different L. iners strains. 
Unexplored health states needs to be studied 
 The vaginal microbiota of adolescence, reproductive age, and post-menopause 
has been well described using cultivation based methods as well as molecular methods. 
The vaginal microbiota during pregnancy has also been described as being less diverse 
and less rich in comparison to reproductive aged non-pregnant women. However, we still 
do not understand the role of the vaginal microbiota in the infectious etiology of preterm 
birth, PPROM and other adverse pregnancy outcomes. Our study was designed 
specifically to address the question whether microbiome at PPROM can predict maternal 
and fetal outcomes. Our study was not designed to conclude whether the microbiome that 
we see after PPROM is a cause or an effect of PPROM. It is also difficult to state the 
reason behind the unstable nature of microbiome during latency, beyond the obvious 
contribution of antibiotic use. However, these questions are critical in improving the 
understanding of clinicians to manage the condition of PPROM. 
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 To fill these gaps in knowledge, it is critical to understand the composition and 
the stability of the postpartum microbiome. Delivery induces abrupt and dramatic 
changes in levels of hormones such as progesterone, estrogen, prolactin, cortisol, 
oxytocin, thyroid, and vasopressin. In addition to that, vaginal pH changes abruptly due 
to the flow of amniotic fluid when membrane rupture occurs prior to delivery. Literature 
describing how hormonal factors and other changes during delivery affects the vaginal 
microbiota and its stability postpartum is limited. The role of host genetics in the vaginal 
ecosystem is still unexplored. We not only need to understand the effects of varying 
health parameters on the vaginal microbiota, but also need to be able to address how the 
metabolic and immunologic components of the vaginal ecosystem change with respect to 
different health status.  
Better diagnostic methods need to replace traditional diagnostic methods  
The gold standard method of diagnosing abnormal vaginal microbiota is the 
Nugent score, which is a weighted scoring system based on abundance of bacterial 
morphotypes defined by Gram stain score. There are many limitations associated with 
this traditional diagnostic method. As already stated, Nugent score might vary based on 
the technical staff scoring the slide. The method is semi-quantitative and low resolution. 
Bacterial morphotypes, recognized as a part of Nugent scoring, has been largely 
identified from data inferred from cultivation-based studies. A recent study (Srinivasan et 
al. 2013) that compared bacterial morphotypes recognized using Nugent scoring method 
to bacteria detected using high-throughput sequencing methods indicated that Gram-
negative rods designated Mobiluncus morphotypes on Gram stain are in fact BVAB1. 
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Srinivasan et al. (2013) demonstrated the presence of BVAB1 and also its abundance 
through microscopic evidence using fluorescence in situ hybridization (FISH). Novel 
species such as BVAB1, BVAB2, Leptotrichia spp., Atopobium spp., and Megasphaera 
spp., not included in the bacterial morphotypes that define Nugent score, are now being 
repeatedly reported as being highly specific for diagnosing BV. As we have seen, Nugent 
scoring can be rendered useless in some cases of women with PPROM as slides do not 
contain cells. In such cases, we require an alternate diagnostic method to describe the 
kind of microbiota present in women to determine the kind of antimicrobial treatment 
that needs to be administered.  
Virulence factors such as sialidase and prolidase are known to be predictors of 
BV. In addition to this, metabolic components in the vagina such as trimethyl amine are 
also described to strongly predict BV. Hence, developing a composite indicator variable 
combining the microbiome, virulence factors, and metabolic components might serve as a 
biomarker and could serve as better diagnostic method.   
To conclude, research needs to focus on generating high resolution profiles in 
combination with other aspects affecting health, considering microbial communities as 
part of human ecosystem. The concept of describing individual species as “pathogens” 
should be constrained, and these organisms should be considered within the context of 
the community as a whole. One needs to remember that in an ecosystem with a diverse 
microbial community, there will be variance associated with the metabolic and virulence 
potential based on the type of microbes in the community and parameters associated with 
the host. If we are able to define health using the above described principle and are able 
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to discriminate healthy from diseased states, we will be successful in generating better 
diagnostic methods that would help clinicians manage diseased states better. 
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